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CHAPTER ONE 
SPOROZOITES, THE INFECTIVE STAGE OF THE MALARIA PARASITE 
General Introduction 

I. Introduction: 
The disease malaria is caused by a parasite, which belongs to the 
genus Plasmodium. This parasite is transferred from one individual to 
another by a mosquito. In both host and mosquito the parasite changes 
its morphology as well as its antigenic composition. 
Four different species of parasites of humans are known namely 
Plasmodium vivax, Plasmodium ovale, Plasmodium malariae, and Plasmodium 
falciparum, the latter being the only lethal one. 
Until recently the disease could be successfully treated with 
chloroquine, quinine and sulfa-pyrimethamine combinations. However, 
reports appear with increasing frequency about multi-resistance of the 
parasite against anti-malarial drugs (1) and about the ineffectivity of 
insecticides against the anopheline vectors. An active immunization of 
the population at risk is being considered as one of the possible 
solutions for the present problems. 
The aim of this study has been to extend the knowledge on the 
immunology and biochemistry of the malarial parasite and in particular 
the sporozoite stage. This project is a further extension of work by 
Verhave (2), who studied the immune response of rodents to sporozoites 
of Plasmodium berghei (ANKA strain). In this thesis results of 
experiments are reported which deal with the sporozoite antigens and 
their role in the anti-sporozoite immunity. 
II. Development and fine structure of sporozoites. 
The sporozoite stage of the malarial parasite starts in the oocyst 
on the midgut wall of the Anopheles mosquito and ends with the 
penetration of the liver cell of the vertebrate host and the 
differentiation into the exo-erythrocytic form (EEF). 
After their maturation in the oocyst, the sporozoites are released 
into the hemocoel of the mosquito. Most of them migrate to and penetrate 
the salivary glands. During this developmental period their infectivity 
increases with time. In Plasmodium berghei this maturation occurred also 
outside the salivary glands (3). Together with the increase in 
infectivity, the immunogenicity and motility of sporozoites increases. 
These findings were extended to the avian parasite Plasmodium 
gallinaceum in later studies by Daher and Krettli (4). Sporozoites 
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present in the hemocoel of the mosquito were as infective as their "twin 
brothers" from the salivary glands. Mixed with saliva they are 
transferred directly or indirectly into the blood of the vertebrate host 
when the mosquito takes its bloodmeal. About 1% of (P.berghei) 
sporozoites present in the salivary glands are actually injected during 
one feed (5). In the blood the sporozoites are subjected to phagocytic 
cells and the sieving effects of spleen and liver. Most of the 
sporozoites are cleared from the circulation in ten minutes after 
inoculation. However, some sporozoites may still be found in the blood 
after one or two hours. Part of those that have reached the liver can 
develop into GEF. From studies by Verhave (2) it appeared that a 
correlation exists between the number of developing EEF and injected 
sporozoites. 
The fine structure of sporozoites of different plasmodia has been 
described by Garnham et al. (6), and Cochrane et al. (7) using thin 
section electron-microscopy and by Aikawa et al. (8), Dubrémetζ et 
al.(9) and Meszoely et al.(10) using freeze fracture techniques. 
Sporozoites of different plasmodial species have a basic architecture in 
common. They are surrounded by a triple membrane; the outer, middle and 
inner membrane. They contain an opening in the pellicle the so-called 
cytostome, the usual subcellular structures like a nucleus, one 
mitochondrion and a very characteristic pattern of microtubules 
localized just beneath the inner membrane in the anterior part of the 
sporozoite. Of particular interest are the micronemes and rhoptries at 
the anterior end of the sporozoite. These organelles probably contain 
the material necessary for the penetration of the membranes of the 
salivary gland and the liver cell. During maturation on the midgut of 
the mosquito certain changes were shown to occur (Dubremetz et al. 9). 
They found an increase in the number of intra-membranous particles 
(iMPs) in the outer sporozoite membrane of which 80% was present in the 
inner fracture face of the outer membrane. This means that during 
maturation the amount of protein in this membrane considerably 
increases, a phenomenon probably responsible for the concomitant 
increase in infectivity, immunogenicity and motility mentioned above 
(3). 
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III. Inmunity against sporozoites 
a. Inmuniza ti on with sporozoites 
From studies of Mulligan et al. in 1941 (11) with avian malaria and 
later of Nus9enzweig and coworkers with mammalian malaria (reviewed in 
(12)) it appeared to be possible to induce protection using sporozoites 
as an immunogen. To prevent the development of a parasitemia during the 
immunization process sporozoites were mostly attenuated by irradiation 
(> 8 kRads of X-rays). These sporozoites, however, were able to induce 
abortive infections in the liver (2). Verhave (2) and Beaudoin et al. 
(13) used viable sporozoites while infections were prevented by 
prophylactic drug treatment. Recently Orjih and Nussenzweig (14) as well 
as Verhave (15) applied both procedures and could not detect any 
difference in the effectiveness of both methods. 
To measure the efficacy of the immunization three criteria have 
been used. 
- The absence of any parasites in the blood for at least two weeks 
after the injection of viable sporozoites. 
- The prolongation of the prepatent period, which is the time gap 
between the infective challenge and the first appearance of parasites in 
the blood. 
- The reduced number of EEF in the liver. (2, 16). 
The results of the immunization experiments with intact sporozoites 
as immunogen were promising. Not only in rodents (12), but also in 
monkeys with P.cynomolgi and P.knowlesi (17) and in human volunteers 
(18, 19, 20) with P. falciparum and P.vivax it appeared possible to 
induce protection by repeated inoculation of attenuated sporozoites. 
Sometimes even 100% of the individuals could be protected. This 
protection was specific for the stage of development in that no 
protection occurred against blood-induced infections. In rodents but not 
in monkeys and humans cross-protection existed against sporozoites of 
different species (12). Mice immunized with P.berghei sporozoites 
resisted a challenge with viable sporozoites of P.berghei and all other 
rodent malarial species (21). 
Less successful were immunizations done with dead sporozoites, 
which were either freeze-thawed or heat-inactivated (22, 23). Although 
ultrastucturally these sporozoites looked hardly damaged (24), only 602 
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of the mice immunized could be protected. Fractions of sporozoites after 
sonication or homogenizat ion were not effective in the induction of 
protective immunity (22). The authors suggested that a partial 
development into EEF might be necessary to induce protection. Others, 
however, still believe that the sporozoite as such is capable of and is 
responsible for inducing protective immunity. They could induce sterile 
anti-sporozoite immunity in mice during causal prophylactic treatment 
with chloroquine and primaquine (25, 26, 27). Orjih and Nussenzweig (14) 
found indications that this treatment somewhat lowered the percentage of 
protected animals. 
Inmunization against sporozoites was only effective via the 
intravenous (i.v.) route. Spitalny and Nussenzweig (22) investigated 
other ways like intramuscular (i.m.), and intraperitoneal (i.p.) routes 
and even per os; only a partial protection could be induced. Kramer and 
Vanderberg (28) had comparable results with the i.m. injection of 
P.berghei sporozoites. They found also that the percentage of protected 
animals could be enhanced when sporozoites were injected in the presence 
of bovine serum albumin. P.knowlesi sporozoites have been administered 
i.m. to monkeys in the presence of Freunds complete adjuvant. This 
immunization procedure, however, did not even result in a significant 
increase of the prepatent period (17). 
The dosage necessary for the induction of 100% protective immunity 
was dependent on the model used. In rodent malaria, P.berghei in mice, 
3 four to seven injections with 5 χ 10 sporozoites were necessary (13), 
using young Wistar rats, however, three exposures to 50 infectious 
о 
mosquitoes were sufficient (16). In simian malaria (17) 3 χ 10 
sporozoites divided over seven occasions were needed. From the few 
experiments with humans it appeared that the bites of 400 to 1000 
infectious mosquitoes in six to eight exposures could induce 100% 
protection. Less than 200 mosquitoes could not induce any protective 
effect (19). The immunogenic dosage was also dependent on whether 
sporozoites were obtained from salivary gland dissections or whole 
mosquitoes. This is due to the lower immunogenicity of immature 
sporozoites present in the fraction derived from whole mosquitoes. 
b. Humoral factors in anti-sporozoite immunity. 
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Anti-eporozoite antibodies play a significant role in the specific 
defense against this stage. In order to be able to correlate the degree 
of protection with the concentration of specific anti-sporozoite 
antibodies, it is necessary to quantify these antibodies in the serum of 
immunized animals. The first serological test using sporozoites in an 
agglutination reaction was reported by Mulligan et al. in 1941 (11). 
Later in 1969, Vanderberg published the circum-sporozoite-precipitation 
(CSP) a kind of "capping" reaction. Incubation of living sporozoites in 
immune serum resulted in the formation of a surface coat of 
immunocomplexes around the sporozoite which at 37 was redistributed 
over the surface, visible as a tail-like precipitate at one end of the 
sporozoite (29). This reaction was shown to be stage and species 
specific in human and simian malaria and correlated well with protection 
(17, 20). Cross-protection in rodent malaria also resulted in 
cross-reaction in CSP (12). A positive CSP, however, did not guarantee 
protection. Spitalny and Nussenzweig (22) could induce a positive CSP 
using sonicated sporozoite fractions but without concomitant protection. 
The neutralizing capacity of the antibodies could be directly assessed 
by another test. Viable sporozoites were incubated with dilutions of the 
immune serum and subsequently injected into non-immune animals. The 
highest serum dilution that prevented infection was a measure of the 
immune status of the vaccinated animal. This test was called the 
sporozoite neutralization assay (SNA). It could be correlated to 
protection until, however, Spitalny et al.(30) found that splenectomized 
mice were partially protected following sporozoite immunization without 
any antibodies detectable by SNA or CSP. Chen et al. (31) extended this 
observation to B-cell deficient mice. 
The role of antibodies in anti-sporozoite immunity has been 
demonstrated also by transfer experiments. Nussenzweig et al. (32) 
transferred hyperimmune antibodies to non-immune mice and detected an 
enhanced clearance of injected viable sporozoites from the bloodstream. 
No protection could be demonstrated in this experiment, although the 
prepatent period was lengthened. Orjih et al.(33) showed that immune 
mice transfer protective antibodies to their offspring via the milk. 
Using the immuno-fluorescence-asay (IFA) these antibodies could be 
detected in the serum of the newborn mice only after two weeks of 
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nurturing by immune mothers. Using foster mothers it was demonstrated 
that these antibodies (igG) were not transferred via the placenta. 
Similar studies were carried out in man by Nardin et al.(34). They could 
demonstrate P.falciparum anti-sporozoite antibodies in children up to 
six months of age. Their mothers had comparable titers. The authors 
stated that these antibodies were transferred via the placenta. The 
newborn young of a rhesus monkey mother, immune against P.knowlesi 
sporozoites, had specific anti-sporozoite titers just lower than its 
mother, for also six months. 
Bray (35) could not detect specific antibodies (CSP) against 
sporozoites in sera from Cambian adults. He stated that the low numbers 
of sporozoites being injected and phagocytosed by macrophages were 
probably insufficient to stimulate the immune system to produce 
anti-sporozoite antibodies. Nardin et al. (36), however, could detect 
antibodies in sera from Cambian children as well as adults reacting 
specifically against P.falciparum sporozoites using CSP and IFA. The 
specific titer increased significantly with the age of the individual. 
51Z of the sera from adults over 50 years old were positive in CSP 
reactions, whereas only 2.5Z of the sera from 5 to 9 year old children 
reacted positively in this test. In an experimental model Orjih et al. 
(37) showed that the presence of a patent parasitemia acted 
immunosuppressively for other than bloodstage antigens. They induced a 
parasitemia in mice by inoculation of infected blood. These animals were 
then injected with irradiated sporozoites. Starting this immunization 
procedure on the fourth day of the infection ( at low parasitemia ) 
resulted in normal IFA antibody titer. Immunizing from day seven of the 
parasitemia onwards depressed the development of detectable antibodies. 
Sporozoite immune mice given a blood-induced infection did not show a 
decrease in titers of anti-sporozoite antibodies. A reduction of the 
parasitemia (to 0.1Z) resulted in a concomitant reduction of the 
immunosuppressive effect. It is not yet known what causes this effect. 
Orjih et al. suggested that the parasitemia possibly depletes 
(sensitized) B- and T-cells, a phenomenon observed by Wyler (38). Nardin 
et al. (36) used the results of this experimental model to explain the 
phenomenon of increasing anti-sporozoite titers with age in the field. 
Since older people have become immune to blood stages of the parasite, 
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they might develop an anti-sporozoite immunity in the absence of the 
imounosuppressing parasitemia. 
Hansen et al.(39) have studied the class of antibodies arising 
during sporozoite immunization. Using a mouse malaria model they showed 
that antibody titers of IgM and IgG ran parallel up to the fourth 
injection with irradiated sporozoites. Apparently every new injection 
gave rise to IgM-type antibodies. Inmediately after giving an 
intravenous challenge with viable sporozoites titers of both classes of 
antibody decreased simultaneously indicating that also IgM antibodies 
might play a role in the effector mechanism of the immune system. 
c. Cell mediated factors in anti-sporozoite immunity. 
Since none of the assays regarding the statue of the humoral part 
of the immune system could reliably predict protection as a result of 
immunization with sporozoites, investigations have been carried out to 
elucidate the role of the cell-mediated factors in the induction and 
maintenance of the specific protection. 
In the previous part (Illb) experiments have been discussed in 
which the transfer of hyperimmune serum to non-immune donors did not 
result in 100% protection (32), but merely in an increase of the 
prepatent period. In later experiments Spitalny et al.(40) demonstrated, 
using athymic mice (nude or thymectomized) as well as mice which were 
sublethally irradiated and reconstituted with B-cells, that these T-cell 
deprived mice could not be immunized to provide 100% protection. In 
these experiments both viable and irradiated sporozoites were used of 
ANKA as well as the NK65 strain of P.berghei. 
T-cells were shown to be necessary for the induction as well as the 
effector phase of the immune response. Chen et al.(31) used В-and T-cell 
deficient mice. T-cell deficient mice were not protected after injection 
of irradiated sporozoites, whereas 70% of the B-cell deficient mice 
could be protected. The infected part (30%) of the latter group of mice 
showed a prolonged prepatent period. The authors of both papers (31, 40) 
concluded that not only T-helper cells are active but also lymphokines 
that stimulate macrophages might be important. In the absence of 
anti-sporozoite antibodies, these activated macrophages could be 
responsible for the relatively high percentage of non-infected mice (see 
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also Hid.). 
Verhave et al (41) were able Co transfer protective immunity with 
cells of immune donors. Acceptor mice were sublethally irradiated and 
reconstituted with cells of immune donors followed by a booster 
β inoculation with irradiated sporozoites. Using 10 immune spleen cells 
together with a booster inoculation of 10 sporozoites they could 
neutralize a challenge of viable sporozoites, given one week after the 
transfer. Inmune thymus cells could not transfer protection. The T-cell 
population within the spleen, however, was shown to be essential for 
optimal results. Killing of these cells using anti-theta serum and 
complement also destroyed the protective capacity. 
Delayed type hypersensitivity reactions have been observed after 
intradermal injection of sporozoite antigen four days following a 
priming intravenous inoculation with attenuated sporozoites (42). 
d. Non-specific defense against sporozoites 
Non-specific clearance by macrophages might also play a role in the 
defense, since most immunizations against sporozoites have been carried 
out using particulate material containing sporozoites as well as 
microbes and mosquito debris. The first data on this subject were 
reported by Spitalny and Nussenzweig (22). They found that a minimum of 
three intraperitoneal inoculations with irradiated sporozoites were 
necessary for mice to survive an intraperitoneal challenge with viable 
sporozoites. When, however, this challenge was given intravenously no 
protection could be observed. Alger and Harant (43) could obtain 
analogous results using normal mosquito tissue as immunogen. This 
phenomenon was thought to be caused by the activation of local 
macrophages or a kind of hypersensitivity reaction. In a later paper 
(44) they describe the artificial induction of a hypersensitivity 
reaction, which could not protect against an intravenous challenge. 
Using formalin-killed EEF merozoites of an avian malaria parasite, 
P.failax, Holbrook et al.(45) could induce a low degree of protection in 
mice against P.berghei sporozoites. 
The influence of inoculations with BCG on the development of 
anti-sporozoite immunity was investigated by Smrkovski and Strickland 
(46). After an intravenous inoculation of BCG 50Z of the mice resisted 
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an infectious challenge with P.berghei sporozoites given ten days later. 
When challenged four weeks later 30Ζ of the mice were still protected. 
This was probably caused by BCG replication and macrophage stimulation. 
More injections with BCG did not result in more protected animals, which 
meant that activated macrophages played a limited role in the clearance 
and killing of viable sporozoites. Following an inoculation with viable 
sporozoites Verhave (2, 47) detected less EEF in animals with an 
existing parasitemia, than in control animals. This same effect was also 
observed during a Babesia infection and after injection of BCG. 
Inoculation of BCG could also induce immunosuppression (46). 
Repeated injections of BCG after the establishment of solid 
anti-sporozoite immunity, reduced the protective effect. It was thought 
that the expression phase of the immune response was hampered by it. In 
later papers (48 and 49) Smrkovski stated that the weakening of the 
immune response, caused by BCG, was a result of a loss of immunological 
memory. 
Pacheco et al.(50) reported that immunization with a single 
intravenous dose of 16,000 irradiated P.berghei sporozoites in mice 
resulted in the protection of 85% of the mice seven days later. This 
percentage dropped quickly but a second peak was observed after 
twenty-eight days (78%). The high number of protected mice after seven 
days was considered to be due to non-specific stimulation of the 
reticulo-endothelial system. However, whether this stimulation is 
essential for the induction of protective anti-sporozoite immunity is 
not yet clear. According to Unanue (review in 51) macrophages and in 
particular la-positive macrophages are necessary for a specific 
T-dependent immune response. After phagocytosing the antigen they would 
stimulate T-cells to produce lymphokines, which attract more activated 
la-positive macrophages to the site of the antigen. 
Young Wistar rats are far more sensitive to infection with 
sporozoites than older rats. Between different rat strains also a 
difference exists in the number of EEF developing after a P.berghei 
sporozoite inoculation (52). Both phenomena are examples of non-specific 
defense against the parasite. It is not known, however, what mechanisms 
are responsible for these differences. 
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IV. Inmunologically significant sporozoite antigens. 
Although immunization with intact eporozoites can be successful it 
is, however, not applicable as a vaccine due to the presence of 
impurities and the lack of preservation methods, apart from the enormous 
quantities needed. 
Therefore more and more attention has been focussed on the 
identification of the antigens as inducers and targets of the 
anti-sporozoite immunity. Both the specificity of the antigens and their 
immunochemical characterization have been investigated. 
a. Specificity of sporozoite antigens. 
Protection was shown to be specific for the species, except in the 
rodent model, and for the stage of development i.e. the sporozoite. 
Since the CSP and SNA were only suitable to eporozoites and not to blood 
stages the applicability of the IFA was tested. This assay could detect 
specific anti-sporozoite antibodies at lower levels than CSP or SNA (36, 
53, 54). Using this technique sera from sporozoite immunized animals 
were tested for cross-reactivity to asexual blood stages. Golenser et 
al. (26) found that sera from rats immunized with P.berghei eporozoites 
reacted with blood schizonts, although the titer was lower than in the 
reaction with the homologous stage. A comparable phenomenon was observed 
using sera from bloodstage immunized rats. In a later study the same 
authors demonstrated that these "cross-reacting" antibodies were in fact 
directed against different antigenic determinants. The antibodies 
directed against one heterologous stage could be absorbed without 
influencing the titer against the homologous stage (16). 
Nardin and Nussenzweig (53) could reduce the cross-reactivity after 
a mild fixation of the P.berghei eporozoites used for slide antigen, or 
by using viable eporozoites for the assay. Nardin et al. (21) applied 
the same technique for P.knowlesi eporozoites. These resulte indicated 
that stage-specific antigens were localized on the surface, whereas 
antigens shared by different stages were present inside the cell. 
Golenser et al. (26) described in 1977 the cross-reactivity of 
anti-sporozoite serum with EEF in P.berghei using the IFA technique. 
Danforth et al. (55) found that antibodies which were "specific" for 
eporozoites, raised in mice by immunization with irradiated P.berghei 
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sporozoites, reacted also with EEF of this species. They demonstrated, 
however, that this reaction was dependent on the age of the liver form. 
Until 30 hours after sporozoite inoculation the reaction was positive. 
From 18 hours onwards, however, the EEF also started to react with 
anti-blood stage antibodies. From 18 to 30 hours the stage-specific 
antigens of both sporozoites and blood forms were present in the EEF. In 
this study fixed liver sections were used as slide antigen. Hollingdale 
(56) described the in vitro development of EEF in human embryonic lung 
cells and found that anti-sporozoite serum reacted also with these forms 
in their abnormal environment. 
Using the IFA technique, sera directed against sporozoites of 
different plasmodial species have been tested on their mutual 
cross-reactivity. From earlier experiments by Tobie et al. (57) it was 
already known that antibodies against the asexual blood forms of one 
primate or human malaria species had a broad reactivity in IFA with most 
other primate and human species. 
Nardin et al. (21) have tested antisera against P.vivax, 
P.falciparum, P.berghei, P.cynomolgi and P.knowlesi sporozoites. As 
antigen they used dried as well as fixed and viable sporozoites. 
Positive reactions were obtained only against homologous sporozoites 
either dried or intact. These results corroborated the findings using 
CSP reactions and correlated with the absence of cross-protection 
between these species (58, 20). 
Using the CSP reaction cross-reactivity had been detected between 
different strains of one species in rodent and simian malaria (12, 58). 
These results were also confirmed in human malaria by Nardin et al. (21) 
using the IFA technique. Sera from patients from different geographical 
areas (Western Africa and South East Asia) reacted with P.falciparum 
sporozoites from the African isolate. Sera against two P.knowlesi 
strains (Phillipine strain and H strain), however, failed to interreact, 
when viable P.knowlesi sporozoites were used as IFA antigen and 
cross-reacted slightly using fixed or dried sporozoites. The authors 
suggested the possibility of a quantitative difference in the amount of 
antigen on the surface of the sporozoites. The presence of a strain 
specific component strongly reacting against the homologous serum as 
well as a second antigen shared by both strains could also explain the 
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observed phenomenon. Even less clear are the data available in rodent 
malaria. Nardin et al. (21) stated that sera from mice immunized with 
P.berghei, P.vinckei vinckei or P.vinckei chabaudi react with 
sporozoites of all other rodent malaria species using the CSP test. The 
investigators, however, have not repeated these experiments using the 
more sensitive IFA technique. Verhave (unpublished results) could not 
confirm the above observations using IFA on gluteraldehyde fixed 
sporozoites. Ramsey et al. (59) did not observe cross-reactivity between 
P.berghei and P.yoelii sporozoites using sera from intravenously 
immunized mice. Sera from mice or rabbits immunized by infected mosquito 
bites did show a slight cross-reaction. As IFA antigen these 
investigators used air dried sporozoites. 
The application of monoclonal antibodies (MoAbs), obtained by the 
now extensively used hybridoma technique of Köhler and Milstein (60), 
stimulated the investigations to determine more exactly the presence of 
specific antigenic determinants on sporozoites. 
In 1980 Yoshida et al. (61) reported the development of a MoAb 
(designated as 3D11) specifically reacting with the surface of the 
sporozoite of P.berghei NK65 and not cross-reacting with P.berghei blood 
stages or sporozoites from simian malaria such as P.knowlesi. Specific 
titers in the IFA were thousand times higher than with serum from immune 
animals. 3D11 gave a homologous CSP reaction two to four times stronger 
than such immune sera. Potocnjak et al. (62) characterized this MoAb as 
belonging to the IgG. subclass. These investigators showed also that 
3D11 could neutralize the infectivity of sporozoites. This, however, 
could not be achieved with P.yoelii nigeriensis sporozoites. A WHO 
report (63) mentioned the development of a MoAb directed against 
P.yoelii nigeriensis sporozoites reacting positively with the surface 
component of P.berghei NK65. It is therefore possible that species 
specific determinants do exist in sporozoites of rodent malaria 
parasites. 
Taylor et al. (64) developed hybridomas from spleen cells of mice 
immunized with blood stages of P.yoelii nigeriensis. They obtained MoAbs 
reacting with sporozoites of the same species but these MoAbs were not 
specific for this stage. 
Danforth (65) has obtained MoAbs against P.berghei sporozoites, 
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which appeared to be stage specific. One МоАЪ(Вб) was both positive in 
CSP and IFA, the other two only gave positive IFA reactions. The latter 
two were IgM, whereas the former belonged to the IgG class. Ramsey et 
al. (59) have used this MoAb (B6) and demonstrated that in IFA it 
reacted only with the homologous (P.berghei) sporozoites and not with 
P.yoelii sporozoites. 
Coworkers of Yoshida and Nueвenzweig developed MoAbs against 
sporozoites of P.knowlesi (Cochrane et al.(66)) and of P.falciparum and 
P.vivax (Nardin et al.(67)). Although polyvalent sera against P.knowlesi 
sporozoites did not react with sporozoites of P.cynomolgi (21), three of 
the nine MoAbs raised against P.knowlesi did show this cross-reactivity 
(66). The MoAbs of P. falciparum and P.vivax did not interreact. The 
infectivity of viable sporozoites of P.falciparum and P.vivax could be 
abolished partially after incubation with the homologous MoAbs. The MoAb 
developed against the S.E. Asian P.falciparum MoAb was also partially 
protective against the sporozoites of the W. African isolate (67). 
The reactivity of polyvalent anti-sporozoite antibodies with young 
EEF were also detectable using 3D11 (P.berghei) both in liver sections 
until 30 hours (68) and in in vitro developed P.berghei EEF in human 
embryonic lung cells (69). These stages thus definitely possess 
antigenic determinants shared with their predecessors, the sporozoites. 
125 Recently a new test has been developed using I-labelled 3D11 
antibodies. Zavala et al. (70) adsorbed infected mosquito homogenste to 
plastic microwelle. After binding of the labelled antibodies they could 
quantify the number of sporozoite infected mosquitoes in a sample of 
vector anophelines. This test can be very useful for epidemiological 
surveys. 
b. Characterization of immunologically significant antigens of 
sporozoites. 
Sporozoite suspensions needed to be purified better before specific 
antigens could be further characterized. Up to now the available 
procedures varied from the dissection of salivary glands of infected 
mosquitoes (71) to the mass harvesting of sporozoites from homogenized 
mosquitoes using density gradients centrifugation (72, 73). The 
resulting suspensions were still heavily contaminated with microbial and 
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mosquito debris. More refined methods were developed. Mack et al. (74) 
and Moser et al. (75) reported the application of DEAE-ion exchangers, 
which should bind th». debris but not the sporozoites. The yield varied 
from 10 to 60%, from either homogenized thoraces (75) or dissected 
salivary glands (74). Wood et al. (76) used a separation based on the 
difference in size instead of a difference in charge of sporozoites and 
debris. Using membrane screen filters optically clean suspensions of 
sporozoites could be obtained which, however, contained many bacterial 
contaminants. Yoshida et al. (61) used affinity columns after dissecting 
salivary glands to remove most of the contaminants. They used 
thyroglobulin and hog gastric mucine coupled to Sepharose 6MB. The 
sporozoite suspension that resulted was treated repeatedly with the 
lectins Concanavalin A (ConA) and Wheat Germ Agglutinin (WGA) to 
agglutinate residual microbes. Sporozoites were still infectious after 
all of the mentioned procedures. 
Yoshida et al. (61) have used this purified suspension as starting 
material to label surface proteins using lactoperoxidase-catalyzed 
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lodination. The size of the labelled proteins could be determined by 
SDS-FAGE. The labelled antigen binding to MoAb 3D11 could be detected as 
being a protein with a MW of 44kD (designated as Pb44). In a later study 
Yoshida et al. (77) demonstrated that this protein is synthesized by the 
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mature sporozoite. By incorporation of S-methionine two proteins were 
labelled with MW of 52kD and 54kD (Pb52 and РЬ54). Both reacted with 
3D11. In chase experiments Pb52 was found to be turning over into Pb44
> 
whereas Pb54 seemed to have a much longer half life. Whether Pb54 is a 
precursor of Pb52 is still uncertain. Both proteins, however, were not 
detectable on the surface of the sporozoite. 
By electron microscopy using ferritin labelled 3D11 Aikawa et al. 
(66) demonstrated that Pb44 was equally distributed over the surface of 
mature sporozoites and scarcely present, in patchy clusters, on the 
surface of oocyst sporozoites. 
Pb44 appeared to have an iso-electric point different from its 
precursors (pI-4.7 for Pb44 and pl=5.2 for Pb52 and Pb54) (77). 
Similar proteins have been found in sporozoites of P.knowlesi 
(Pk521 Pk50 >Pk42) by Cochrane et al. (66) of P.vivax (Pv51, Pv45) and 
P. falciparum (Pf67 and Pf58) by Nardin et al. (67). The latter study 
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only reports about S-methionine incorporation without chase 
experiments or surface labelling the size of the surface component is 
therefore still not known. The proteins were all shown to be species 
specific. In the human malaria species two proteins were synthesized 
PfBO and Р Ув, which were both recognized by sera from volunteers 
immunized with sporozoites of the heterologous species. 
Fab fragments of the homologous MoAbs were able, as were the intact 
antibodies, to neutralize the infectivity of viable sporozoites. (62, 
66, 67). They also could block sporozoites in the attachment and 
penetration of human embryonic lung cells in vitro (69). It is therefore 
suggested that this "family" of proteins exerts a ligand function in the 
penetration of sporozoites into the host cell (67). 
Several investigators have looked for specific carbohydrate 
moieties on the surface of sporozoites of P.gallinaceum (78), P.berghei 
(79, 21) and P.knowlesi (21) using fluorescein-conjugated lectins 
without, however, any success. Schulman et al. (79) did find a positive 
reaction using ConA and Ricinus Communis Agglutinin I (RCA I), when 
sporozoites were previously incubated with homologous non-immune serum. 
The same was valid for oocyst sporozoites. Holmberg et al. (80) 
demonstrated the presence of a factor in hamster serum, which could 
enhance the adherence of P.berghei sporozoites to mouse peritoneal 
macrophages. This factor could bind to ConA. These investigators had the 
impression that the ligand for the sporozoite-macrophage contact is a 
glycoprotein or glycolipid, which is of serum origin and not a 
sporozoite component. Alving (81) also found indications that specific 
oligosaccharides were involved in the penetration of host cells by 
sporozoites. Liposomes charged with galactose bearing glycolipids given 
intravenously to mice, which were 24 hours previously injected with 
viable sporozoites, could block infection of hepatocytes, whereas 
liposomes bearing other oligosaccharides could not interfere with 
infection. Whether the receptor for the ligand present on the sporozoite 
is situated on the surface of Rupffer cells or hepatocytes, is not yet 
clear. Substantial evidence, however, is available that at least in the 
experimental model used by Meis et al.(52) Kupffer cells are involved in 
the transfer of sporozoites to hepatocytes. 
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V. This study. 
The study of which the results are described in this thesis, mainly 
deals with the characterization and purification of sporozoite surface 
antigens (chapter II and III). Since our results differ in detail from 
those of the "Nussenzweig" group in New York we have investigated the 
cause of this divergence as described in chapter IV. Since in the up to 
date literature no reports are available about immunization experiments 
using purified sporozoite proteins, we have developed a model for the 
presentation of the immunogenic sporozoite protein, using liposomes as 
carrier-membranes. The results of these experiments have been described 
in chapter V. In the last chapter the results have been summarized and 
suggestions for further research in this field of interest have given. 
This project was carried out under the auspices of the Netherlands 
Foundation for Biological Research with financial aid from the 
Netherlands Organization for the Advancement of Pure Research (ZWO) 
grant no: 14.95.04 . These studies were part of a malaria research 
progranme which has been supported by a grant from the World Health 
Organization/UNDP/World Bank Special Programme. 
26 
REFERENCES 
1. UNDP/World Bank/Vrao Update (1983) Development of Mefloquine as an 
antimalarial drug. Bull.W.H.O. 61, 169-178. 
2. Verhave, J.P., (1975) Inmunization with sporozoitee: An experimental 
study of Plasmodium berghei malaria. PhD. Thesis. Catholic 
University of Nijmegen, The Netherlands. 
3. Vanderberg, J.P. (1975) Development of infectivity by the Plasmodium 
berghei sporozoite. J. Parasitol. 61, 43-50. 
4. Daher, V.R., Krettli, A.U. (1980) Infectivity of Plasmodium 
gallinaceum sporozoitee from oocysts. J. Protozool. 27, 440-442. 
5. Vanderberg, J.P. (1977) Plasmodium berghei: Quantitation of 
sporozoitee injected by mosquitoes feeding on a rodent host. Exp. 
Parasitol. 42, 169-181. 
6. Garnham, P.C.C., Bird, R.G., and Baker, J.R. (1963) E.M. studies on 
motile stages of malaria IV. The fine structure of the sporozoites 
of four species of Plasmodia. Trans. Roy. Soc. Trop. Med. Hyg. 57, 
27-31. 
7. Cochrane, A.H., Aikawa, M., Jeng, M., and Nus9enzweig, R.S. (1976) 
Antibody-induced ultrastructural changes of malarial sporozoites. J. 
Immunol. 116, 859-867. 
8. Aikawa, M. , Cochrane, A.H., and Nussenzweig, R.S. (1979) A freeze 
fracture study of malarial sporozoites: Antibody induced changes of 
the pellicular membranes. J. Protozool. 26, 273-279. 
9. Dubremetz, J.F., Torpier, G., Maurois, P., Prensier, G., Binden, R. 
(1979) Structure de la pellicule du sporozoite de Plasmodium yoelii: 
étude par cryofracture. C. R. Acad. Sci. Paris série D. 288, 
623-626. 
10. Meszoely, C.A.M., Erbe, E.F., Steere, R.L., Pacheco, N.D., Beaudoin, 
R.L. (1982) Plasmodium berghei: architectural analysis by 
freeze-fracturing of the intra-oocyst sporozoite's pellicular 
system. Exp. Parasitol. 53, 229-241. 
11. Mulligan, H.W., Russell, P.F., and Mohan, B.N. (1941) Active 
immunization of fowls against Plasmodium gallinaceum by injection of 
killed homologous sporozoites. J. Malar, Inst. India 4, 25-34. 
12. Nussenzweig, R.S., Vanderberg, J.P., Spitalny, G., Rivera, d . O . , 
27 
Orton, С , and Moet, H. (1972) Sporozoite-induced ішпшпісу in 
mammalian malaria: A review. Am. J. Trop. Med. Hyg. 21, 722-728. 
13. Beaudoin, R.L., Strome, С.P.Α., Tubergen, Τ.Α., and Mitchell, F. 
(1976) Plasmodium berghei berghei: Irradiated sporozoitee of the 
ANKA strain as immunizing antigens in mice. Exp. Parasitol. 39, 
438-443. 
14. Orjih, A.U., and Nussenzweig, R.S. (1980) Immunization against 
rodent malaria with cryopreserved irradiated sporozoites of 
Plasmodium berghei. Am. J. Trop. Med. Hyg. 29, 343-347. 
15. Verhave, J.P. (1982) Invasion of host cells by malaria parasites. 
in: Immunoparasitology. eds. Strickland, G.T., and Hunter, K.W. pp 
13-23. Praeger Publishers. 
16. Golenser, J., Verhave, J.P., De Valk, J., Heeren, J., and Meuwissen, 
J.H.G.Th. (1978) Studies on the role of antibodies against 
sporozoites in Plasmodium berghei malaria. Isr. J. Med. Sci. 14, 
606-610. 
17. Gwadz, R.W., Cochrane, A.H., Nussenzweig, V. and Nussenzweig, R.S. 
(1979) Preliminary studies on vaccination of rhesus monkeys with 
irradiated sporozoites of Plasmodium knowlesi and characterization 
of surface antigens of these parasites. Bull. W.H.O. 57, Suppl. 1, 
165-173. 
18. Clyde, D.F., McCarthy, V., Miller, R.M., and Woodward, W.E. (1975) 
Immunization of man against falciparum and vivax malaria by use of 
attenuated sporozoitee. Am. J. Trop. Med. Hyg. 24, 397-401. 
19. Rieckmann, K.H., Beaudoin, R.L., Cassells, J., and Sell, K. (1979) 
Clinical studies with a sporozoite vaccine against falciparum 
malaria. Bull. W.H.O. 57, Suppl. 1., 261-265. 
20. McCarthy, V., and Clyde, D.F. (1977) Plasmodium vivax: Correlation 
of circumsporozoite precipitation (CSP) reaction with 
sporozoite-induced protective immunity in man. Exp. Parasitol. 41, 
167-171. 
21. Nardin, E.H., Nussenzweig, R.S., and Gwadz, R.W. (1979) 
Characterization of sporozoite surface antigens by indirect 
immunofluorescence: Application of this technique to detect stage 
and species specific antimalarial antibodies. Bull. W.H.O. 57, 
Suppl. 1, 211-217. 
28 
22. Spitalny, G.L., and Nussenzweig, R.S. (1972) Effect of various 
routes of immunization and methods of parasite attenuation on the 
development of protection against sporozoite-induced rodent malaria. 
Proc. Helminthol. Soc. Wash. 39, 506-514. 
23. Alger, N.E., and Harant, J. (1976) Plasmodium berghei: Heat treated 
eporozoite vaccination of mice. Exp. Parasitol. 40, 261-268. 
24. Jakstys, B.P., Alger, N.E., Harant, J.Α., and Silverman, P. (1974) 
Ultrastructural analysis of Plasmodium berghei sporozoite antigens 
prepared by freeze-thawing and heat inactivation. J. Protozool. 21, 
344-348. 
25. Beaudoin, R.L., Strome, С.P.Α., Mitchell, F., and Tubergen, T.A. 
(1977) Plasmodium berghei: Immunization of mice against the ANKA 
strain using unaltered sporozoites as an antigen. Exp. Parasitol. 
42, 1-5. 
26. Golenser, J., Heeren, J., Verhave, J.P., van der Kaay, H.J., and 
Meuwissen, J.H.E.Th. (1977) Cross-reactivity with sporozoites, 
exoerythrocytic forms and blood schizonts of Plasmodium berghei in 
indirect fluorescent antibody tests with sera of rats immunized with 
sporozoites or infected blood. Clin. Exp. Immunol. 29, 43-51. 
27. Meuwissen, J.H.E.Th., Golenser, J., and Verhave, J.P. (1978) 
Development of effective antisporozoite immunity by natural bites of 
Plasmodium berghei-infeeted mosquitoes in rats under prophylactic 
treatment with various drug regimens. Isr. J. Med. Sci. 14, 601-605. 
28. Kramer, L.D. and Venderberg, J.P. (1975) Intramuscular immunization 
of mice with irradiated Plasmodium berghei sporozoites. Am. J. Trop. 
Med. Hyg. 24, suppl. 1, 913-916. 
29. Vanderberg, J.P., Nussenzweig, R., and Most, H. (1969) Protective 
immunity produced by injections of X-irradiated sporozoites of 
Plasmodium berghei. V. In vitro effects of imune serum on 
sporozoites. Mil. Med. 134, Suppl., 1183-1190. 
30. Spitalny, G.L., Rivera-Ortiz, C.I., and Nussenzweig, R.S. (1976) 
Plasmodium berghei: the spleen in sporozoite-induced immunity to 
mouse malaria. Exp. Parasitol. 40, 179-188. 
31. Chen, D.H., Tigelaar, R.E., and Weinbaum, F.I. (1977) Immunity to 
sporozoite-induced malaria infection in mice. I. The effect of 
immunization of Τ and В cell-deficient mice. J. Immunol. 118, 
29 
1322-1327. 
32. Nussenzweig, R.S., Vanderberg, J.P., Sanabria, Y., and Moet, H. 
(1972) Plasmodium berghei: Accelerated clearance of sporozoites from 
blood as part of immune mechanism in mice. Exp. Parasitol. 31, 
88-97. 
33. Orjih, A.U., Cochrane, A.H., Nussenzweig, R.S. (1981) Active 
immunization and passive transfer of resistance against 
sporozoite-induced malaria in infant mice. Nature 291, 331-332. 
34. Nardin, E.H., Nussenzweig, R.S., Bryan, J.H., McGregor, I.A. (1981) 
Congenital transfer of antibodies aginst malarial sporozoites 
detected in Cambian infants. Am. J. Trop. Med. Hyg. 30, 1159-1163. 
35. Bray, R.S. (1978) Absence of circumeporozoite antibodies in areas of 
hyperendemic malaria. J. Parasitol. 64, 410. 
36. Nardin, E.H., Nussenzweig, R.S., McGregor, I.A., Bryan, J.H. (1979) 
Antibodies to sporozoites: Their frequent occurrence in individuals 
living in an area of hyperendemic malaria. Science 206, 597-599. 
37. Orjih, A.U., and Nussenzweig, R.S. (1979) Plasmodium berghei: 
Suppression of antibody response to sporozoite stage by acute blood 
stage infection. Clin. Exp. Immunol. 38, 1-8. 
38. Wyler, D.J. (1976) Peripheral lymphocyte subpopulatione in human 
falciparum malaria. Clin. Exp. Immunol. 23, 471-476. 
39. Hansen, R., de Silva, S., and Strickland, G.T. (1979) Antisporozoite 
antibodies in mice immunized with irradiation attenuated Plasmodium 
berghei sporozoites. Trans. Roy. Soc. Trop. Med. Hyg. 73, 574-578. 
40. Spitalny, G.L., Verhave, J.P., Meuwissen, J.H.E.Th., and 
Nussenzweig, R.S. (1977) Plasmodium berghei: T-cell dependence of 
sporozoite-induced immunity in rodents. Exp. Parasitol. 42, 73-81. 
41. Verhave, J.P., Strickland, G.T., Jaffe, H.A., and Ahmed, A. (1978) 
Studies on the transfer of protective immunity with lymphoid cells 
from mice immune to malaria sporozoites. J. Immunol. 121, 1031-1033. 
42. Verhave, J.P., and Strickland, G.T. (1983) Delayed type 
hypersensivity and protection in mice following immunization with 
Plasmodium berghei sporozoites. Manuscript in preparation. 
43. Alger, N.E., and Harant, J. (1976) Plasmodium berghei: Protection 
against sporozoites by normal mosquito tissue vaccination of mice. 
Exp. Parasitol. 40, 269-273. 
30 
44. Alger, N.E., and Ηагant, J. (1976) Plasmodium berghei: sporozoite 
challenge, protection and hypersensitivity in mice. Exp. Farasitol. 
40, 273-280. 
45. Holbrook, T.W., Spitalny, G.L., Palczuk, N.C. (1976) Stimulation of 
resistance in mice to sporozoite induced Plasmodium berghei malaria 
by injections of avian exoerythrocytic forms. J. Parasitol. 62, 
670-675. 
46. Smrkovsky, L.L., and Strickland, G.T. (1978) Rodent malaria: 
BCG-induced protection and immunosuppression. J. Immunol. 121, 
1257-1261. 
47. Verhave, J.P., Meuwissen, J.H.E.Th., and Golenser, J. (1980) The 
dual role of macrophages in the sporozoite-induced malaria 
infection. A hypothesis. Int. J. Nucl. Med. Biol. 7, 149-157. 
48. Smrkovsky, L.L. (1981) Effect of route of Mycobacterium bovis BCG 
administration on induction of suppression of sporozoite immunity in 
rodent malaria. Inf. Immun. 31, 408-412. 
49. Smrkovsky, L.L. (1981) Kinetics of immunosuppression of 
sporozoite-induced immunity by Mycobacterium bovis BCG. Inf. Immun. 
37, 1021-1027. 
50. Pacheco, N.O., McConnell, E., and Beaudoin, R.L. (1979) Duration of 
immunity following a single vaccination with irradiated sporozoites 
of Plasmodium berghei. Bull. W.H.O. 57, Suppl. 1, 159-163. 
51. Unanue, E.R. (1980) Cooperation between mononuculear phagocytes and 
lymphocytes in immunity. New Engl. J. Med. 303, 977-985. 
52. Meis, J.F.G.M., Verhave, J.P., Jap, P.H.K., Sinden, R.E., and 
Meuwissen, J.H.E.Th. (1983) Malaria parasites-discovery of the early 
liver form. Nature 302 424-426. 
53. Nardin, E.H., and Nussenzweig, R.S. (1978) Stage-specific antigens 
on the surface membrane of sporozoites of malaria parasites. Nature 
274, 55-57. 
54. Bawden, M.P., Palmer, T.T., Leef, M.F., and Beaudoin, R.L. (1979) 
Malaria vaccination with irradiated sporozoites: Serologic 
evaluation of the antigen and antibody responses. Bull. W.H.O. 57, 
Suppl. 1, 205-209. 
55. Danforth, H.D., Orjih, A.U., and Nussenzweig, R.S. (1978) 
Inmunofluorescent staining of exoerythrocytic schizonts of 
31 
Plasmodium berghei in fixed liver tissue with stage specific immune 
sera. J. Parasitol. 64, 1123-1125. 
56. Hollingdale, M.R., Leef, J.L., McCullough, M., Beaudoin, R.L. (1981) 
In vitro cultivation of the exoerythrocytic stage of Plasmodium 
berghei from sporozoites. Science 213, 1021-1022, 
57. Tobie, J.E., Kuvin, S.F., Contacos, P.G., Coatney, G.R., and Evans, 
C.B. (1962) Fluorescent antibody studies on cross reactions between 
human and simian malaria in normal volunteers. Am. J. Trop. Med. 
Hyg. 11, 589-596. 
58. Chen, D.H., Nüssenzweig, R.S., and Collins, W.E. (1976) Specificity 
of the circumsporozoite precipitation antigen(s) of human and simian 
malarias. J. Parasitol. 62, 636-637. 
59. Ramsey, J.M., Beaudoin, R.L., Bawden, M.P., and Espinal, С.A. (1983) 
Specific identification on Plasmodium sporozoites using an indirect 
fluorescent antibody method. Trans. Roy. Soc. Trop. Med. Hyg. 77, 
378-381. 
60. Köhler, G., and Milstein, C. (1975) Continuous cultures of fused 
cells secreted antibody of predefined specificity. Nature 256, 
495-497. 
61. Yoshida, N., Nussenzweig, R.S., Potocnjak, P., Nussenzweig, V., and 
Aikawa, M. (1980) Hybridoma produces protective antibodies directed 
against the sporozoite stage of malaria parasite. Science 207, 
71-73. 
62. Potocnjak, P., Yoshida, N., Nussenzweig, R.S., and Nussenzweig, V. 
(1980) Monovalent fragments (Fab) of monoclonal antibodies to a 
sporozoite surface antigen (Pb44) protect mice against malarial 
infection. J. Exp. Med. 151, 1504-1513. 
63. Scientific Working Group on the Immunology of Malaria (1981) 
Antigenic structure and related aspects of the biology of Plasmodia; 
the present situation. Bull. W.H.O. 59, 371-378. 
64. Taylor, D.W., Kim, K.J., Munoz, P.A., Evans, C.B., and Asofsky, R. 
(1981) Monoclonal antibodies to stage-specific, species-specific and 
cross-reactive antigens of the rodent malarial parasite Plasmodium 
yoelii. Inf. Immun. 32, 563-570. 
65. Danforth, H.D., Campbell, G.H., Leef, M.F., and Beaudoin, R.L. 
(1982) Production of monoclonal antibodies by hybridomas sensitized 
32 
to sporozoites of Plasmodium berghei. J. Parasitol. 68, 1029-1033. 
66. Cochrane, A.H., Santoro, F., Nussenzweig, V., Gwadz, R.W., and 
Nussenzweig, R.S. (1982) Monoclonal antibodies identify the 
protective antigens of sporozoites of Plasmodium knowlesi. Proc. 
Natl. Acad. Sci. U.S.A. 79, 5651-5655. 
67. Nardin, E.H. Nussenzweig, V., Nussenzweig, R.S., and Collins, W.E., 
Harinasuta, K.T., Tapchaisri, P., and Chomcharn, Y. (1982) 
Circumsporozoite proteins of human malaria parasites Plasmodium 
falciparum and Plasmodium vivax. J. Exp. Med. 156, 20-30. 
68. Aikawa, M., Yoshida, N., Nussenzweig, R.S., and Nussenzweig, V. 
(1981) The protective antigen of malarial sporozoites (Plasmodium 
berghei) is a differentiation antigen. J. Immunol. 126, 2494-2495. 
69. Hollingdale, M.R., Zavala, F, Nussenzweig, R.S., and Nussenzweig, V. 
(1982) Antibodies to the protective antigen of Plasmodium berghei 
sporozoites prevent entry into cultured cells. J. Immunol. 128, 
1929-1930. 
70. Zavala, F., Gwadz, R.W., Collins, F.H., Nussenzweig, R.S., and 
Nussenzweig, V. (1982) Monoclonal antibodies to circumsporozoite 
proteins identify the species of malaria parasites in infected 
mosquitoes. Nature 299, 737-738. 
71. Bosworth, A.B., Schneider, J., and Freier, J.E. (1975) Mass 
isolation of Anopheles stephensi salivary glands infected with 
malarial sporozoites. J. Parasitol. 61, 769-772. 
72. Krettli, Α., Chen, D.H., and Nussenzweig, R.S. (1973) Immunogenicity 
and infectivity of sporozoites of mammalian malaria isolated by 
density gradient centrifugation. J. Protozool. 20, 662-665. 
73. Pacheco, N.D., Strome, С.P.Α., Mitchell, F. Bawden, M.P., and 
Beaudoin, R.L. (1979) Rapid large scale isolation of Plasmodium 
berghei sporozoites from infected mosquitoes. J. Parasitol. 65, 
414-417. 
74. Mack, S.R., Vanderberg, J.P., and Nawrot, R. (1978) Column 
separation of Plasmodium berghei sporozoites. J. Parasitol. 64, 
166-168. 
75. Moser, G., Brohn, F.H., Danforth, H.D., and Nussenzweig, R.S. (1978) 
Sporozoites of rodent and simian malaria purified by anion 
exchangers, retain their immunogenicity and infectivity. J. 
33 
Protozoo!. 25, 119-124. 
76. Wood, D.E., Smrkovsky, L.L., McConnell, E., Pacheco, N.D., and 
Bawden, M.P. (1979) The use of membrane screen filters in the 
isolatio of Plasmodium berghei sporozoites from mosquitoes. Bull. 
W.H.O. 57, Suppl 1, 69-74. 
77. Yoshida, N., Potocnjak, P., Nussenzveig, V., and Nussenzweig, R.S. 
(1981) Biosynthesis of Pb44, the protective antigen of sporozoites 
of Plasmodium berghei. J. Exp. Med. 154, 1225-1236. 
78. Turner, D.P., and Gregson, N.A. (1982) The cell surface of 
Plasmodium gallinaceum sporozoites: microelectrophoretic and 
lectin-binding characteristics. Parasitology 84, 227-238. 
79. Schuimen, S., Oppenheim, J.D., Vanderberg, J.P. (1980) Plasmodium 
berghei and Plasmodium knowlesi: Serum binding to sporozoites. Exp. 
Parasitol. 49, 420-429. 
80. Holmberg, S., Schulman, S., Vanderberg, J.P. (1981) Role of a serum 
factor in enhancement of in vitro interactions between Plasmodium 
berghei sporozoites and hamster peritoneal macrophages. J. 
Parasitol. 67, 893-897. 
81. Alving, CR., Schneider, I, Swart ζ Jr., G.M., Steck, E.A. (1979) 
Sporozoite-induced malaria: Therapeutic effects of glycolipids in 
liposomes. Science 205, 1142-1144. 
34 
CHAPTER TWO 
PLASMODIUM BERGHEI: IMMUNOLOGICALLY ACTIVE PROTEINS ON 
THE SPOROZOITE SURFACE 
A.N. Vermeulen, J.C. van Munster, and J.H.E.Th. Meuwissen 
Department of Medical Parasitology, University of Nijmegen, Nijmegen, 
The Netherlands. 
Published in Experimental Parasi tology 53, 199-208 (1982) 
36 
Plasmodium berghei: Immunologically Active Proteins on the 
Sporozoite Surface 
Α. N. VERMEULEN, J. С. VAN MUNSTER, AND J. Η. E. Тн. MEUWISSEN 
Department of Medical Parasitology, University of Nijmegen, Nijmegen, The Netherlands 
(Accepted for publication 23 February 1981) 
VFRMEULEN, A N., VAN MUNSTER, J С , AND MEUWISSEN, J Η. E TH 1982 Plas­
modium berghei Immunologically active proteins on the sporozoite surface Experimental 
Parasitology 53, 199-208. With an improved separation procedure for Plasmodium herghei 
sporozoites, up to 2000 mosquitoes can be processed in 3 to 4 hr The method is based on 
density gradient centnfugation in Percoli The small amount of contaminating microbial 
material did not noticeably interfere with the radiolabelmg of surface proteins of the punfied 
sporozoites Two labeled proteins, with molecular weights of about 110,000 and 53,000 
daltons, respectively, were identified using sodium dodecyl sulfate-polyacrylamide gel 
electrophoresis Both proteins reacted specifically with antibodies against salivary gland 
sporozoites raised in rabbits and in rats These two proteins were also present on the surface 
of "immature" sporozoites isolated from mosquitoes 12 days after the infective blood meal 
None of these proteins, apparently, is involved in the cross-reactivity of sporogonie stages 
with blood stages 
INDEX DESCRIPTORS Plasmodium berghei, Malaria, rodent. Protozoa, parasitic, 
Antigens, sporozoite. Surface labeling, Sporozoite purification, Gradient centnfugation, 
Percoli, Staphylococcus aureus. Protein A; Solubilization, Gel electrophoresis. Rat, Rabbit, 
Antibody 
INTRODUCTION 
It has become evident that immunity to 
Plasmodium spp. is complex and based on 
specific immune responses against the de­
velopmental stages of the parasites. Stage-
specific antigens are apparently carried by 
sporozoites (Golenser et al. 1978; Nardin 
and Nussenzweig 1978), gametes (Carter et 
al. 1979), and possibly merozoites (Miller et 
al. 1977; Richards et al. 1977). Antigens on 
the surface of such extracellular stages-as 
sporozoites are of special importance since 
they are thought to be involved in the in­
duction of stage-specific functional immun­
ity (Yoshida et al. 1980). In this study of the 
surface antigens of Plasmodium berghei 
sporozoites, we present an improved 
method for their isolation from infected 
mosquitoes. This made it possible to apply 
surface labeling techniques for the analysis 
of sporozoite antigens. 
MATERIALS AND METHODS 
Purification of sporozoites. Purification 
was a combination of a biphasic urografin 
gradient as described by Pacheco et al. 
(1979) and a continuous Percoli gradient. 
Up to 2000 female Anopheles stephensi 
mosquitoes, of which at least 40% were in­
fected with Plasmodium berghei (ANKA), 
were ground in an all-glass homogenizer in 
200 ml of Medium 199 (М199, Flowlabs) 
adjusted to pH 7.2 using sodium bicarbo­
nate. All further procedures were carried 
out at 4 С unless otherwise mentioned. 
The suspension was centrifuged for 5 min 
at 50£ to remove the larger mosquito frag-
ments. The pellet was washed once with 
M199 and supematants were pooled. The 
sporozoites were pelleted by centnfugation 
of these supernatants at 16,000^ for 10 min 
in a Sorvall Hb4 swing-out rotor. This pellet 
was resuspended in 2 ml of M199 and 
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layered on top of a biphasic gradient con 
sisting of two different mixtures of Uro-
grafin-60 (Schering, Berlin), M199, and 
calf serum, in the following ratios upper 
layer, Urografin-60/M199/calf serum = 
2 4 1, and bottom layer, Urografm-60/ 
M199/calf serum = 3 3 1 The total volume 
of one gradient was 28 ml The homogenate 
of not more than 400 mosquitoes could be 
loaded on such a gradient After centnfu-
gation for 30 mm at 16,000g in a Servali 
Hb4 rotor, the sporozoites were harvested 
from the interphase, they were resuspended 
in 3 vol of M199 and pelleted by centnfuga-
tion for 10 mm at 16,000g This pellet was 
resuspended in S 0 ml of medium 
Before use, 90 ml Percoli (Pharmacia 
Fine Chemicals, lot 7997, density 1 129 
g/ml) was mixed with 10 ml of 9% NaCl to 
make the Percoli isotonic (Pertoft el al 
1978) Five milliliters of this Percoli stock 
solution was mixed with the 5 0 ml spo-
rozoite suspension The density of this 
solution was 1 066 g/ml Centnfugation was 
carried out in a Beekman 50 Τι fixed angle 
rotor for 30 mm at 27,000g Fractions (0 3 
ml) were collected from the top of the gra­
dient by using a Buchler Autodensiflow He 
combined with a fraction collector This 
procedure was carried out at room temper­
ature 
The fractions were examined by phase-
contrast microscopy and those fractions 
that contained an appreciable number of 
relatively clean sporozoites were pooled, 
diluted five times with M199, centnfuged 
for 10 mm at 16,000g, and used immediately 
for labeling 
Samples were taken from the starting 
material, after the biphasic gradient and 
after the Percoli gradient in order to de­
termine the number of microorganisms at 
difierenl stages of purification After esti­
mating the number of sporozoites, the sus­
pension was plated on blood agar plates, 
incubated for 24 hr at 37 C, and the colo­
nies counted The Percoli gradient improved 
the sporozoite/bactenum ratio up to 100 
times compared with the biphasic urografin 
gradient Furthermore, after Percoli cen­
tnfugation the pure fractions were also free 
of mosquito debris Usually 40-60% of the 
sporozoites in the crude homogenate could 
be recovered Sporozoites purified by this 
method were viable as shown by their ca­
pacity to induce a parasitemia in mice fol­
lowing intravenous inoculation A quan­
titative assessment of viability was not car 
ned out because of the large amount of 
sporozoites necessary for these tests and in 
view of the variation in viability of different 
batches 
Labeling procedure Percoll-punfied 
sporozoites were labeled with iodine-125 
based on the procedure of Hubbard and 
Cohn (1972) Sporozoites 2 x 107 were 
radiolabeled using 600 m/units lactoperoxi-
dase (Sigma), 120 m/umts glucose oxidase 
(Merck), 10 /u.mol glucose, 1 mCi N a 1 " ! 
(Radiochemical Centre, Amersham) in 100 
μΙ PB310 buffer, pH 7 2 (Dodge et al 1963), 
during 30 min at 37 С The reaction was 
stopped by adding 9 vol of cold 5 mM cys-
teme-HCl in PBS, pH 7 2, containing 
0 1% potassium iodide Free iodide was 
washed away by centnfuging five times for 
3 mm at 18,000^ in a hematocrit centrifuge 
(Heraeus Chnst) adapted for disposable 
cups (bppendorf) About 10% of total ac 
tivity was bound to the pellet containing the 
sporozoites 
Solubilization of labeled proteins In 
order to solubilize the labeled surface pro­
teins, the radiolabeled sporozoites were re­
suspended in 1 ml of a solution of 10 mM 
Tris-HCl, pH 7 2, containing 1% Triton 
X-100 (Packard scintillation grade) and 
5 mM phenylmethanesulfonyl Fluoride 
(Merck) (PMSF) to inhibit proteolytic 
cleavage After incubation for 2 hr at 37 С 
or for 18 hr at 4 C, a sample indicated as 
"total labeled proteins," was taken for 
examination on SDS-polyacrylamide gel 
electrophoresis (SDS-PAGE) The sus­
pension was then centnfuged for 15 mm at 
I8,000g and the supernatant containing 
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FIG. 1 Schematical procedure for solubilization 
and immunoprecipitation of labeled proteins of 
punPied Plasmodium berghei sporozoites. SaCI, 
Staphylococcus aureus Cowan I, Tns-DTT, 0.062 M 
Tns buffer, pH 6.8, containing 0.04% dithiothreitol 
and 2% sodium dodecyl sulfate. SDS-PAGE, sodium 
dodecyl sulfate-Polyacrylamide gel electrophoresis. 
about 50% of the total activity was used as 
"Triton X-100-soluble proteins." A sample 
of this was also examined on SDS-PAGE 
in order to determine which proteins were 
solubilized by Triton X-100 (see Fig. 1). 
SDS-Polyacrylamide gel electrophore­
sis (SDS-PAGE). The protein sample was 
mixed with the same volume of a solution 
containing 2% SDS, 0.062 M Tris-HCl, pH 
6.8, 0.04% dithiothreitol (DTT), 10% glyc­
erin, and bromophenol blue added as a 
tracking dye (TD). This mixture was boiled 
for 3 min, layered on top of a 7.5% acryl-
amide-0.2% bisacrylamide gel rod, con­
taining 0.1% SDS, and electrophoresed 
with 3 mA/rod until the tracking dye had 
run over the length of the gel. All further 
experimental conditions were as described 
by Laemmli (1970). After electrophoresis, 
the gels were frozen and sliced into 1-mm 
pieces. The radioactivity in the slices was 
estimated in a LKB-Wallac gamma scintil­
lation counter. 
Molecular weights were determined by 
running calibration proteins in separate gels 
in every experiment. RNA-polymerase β' 
and β chain (MW, 165,000 and 155,000 
daltons, respectively), bovine serum albu­
min (BSA) (MW, 68,500 daltons), and 
RNA-polymerase α chain (MW, 39,000 
daltons) (Boehringer, Mannheim) were 
used as calibration proteins. Every sample 
was electrophoresed in duplicate in order to 
eliminate any artifacts that may have been 
introduced by the method employed. 
Immunoprecipitation of labeled anti­
gens. Triton-solubilized antigens (TSA) 
were precipitated with different antisera 
according to the procedure of Nillson and 
Wigzell (1978). Protein Α-bearing Staphy­
lococcus aureus Cowan I (SaCI) was used 
as solid phase to adsorb the immunocom-
plexes formed after incubation of Triton 
X-100-soluble proteins with different sera. 
5. aureus Cowan I was cultured in fluid 
CCY medium (Arvidson et al. 1971), har­
vested, and fixed as described by Cullen 
and Schwartz (1976) and frozen in aliquots 
as 10% suspensions at -70 C. Fifty micro­
liters of Triton X-100-soluble proteins was 
incubated with an equal volume of anti-
sporozoite serum for 2 hr at 33 C. When rat 
serum was used, rabbit-anti-rat IgG 
antibodies (Miles) were added to improve 
the binding to Protein A. After the period of 
incubation, 10-20 mg SaCI was added, 
mixed, and allowed to bind IgG for 2 hr at 
33 C. The bacterial suspension was centri-
fuged for 10 min at 700£. Nonbound mate-
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rial was removed by three washings with 10 
mM Tris-HCI, pH 7.2-1% Triton X-100. 
The Protein A-AbAg* complex was split 
by boiling the bacteria for 3 min in a solu­
tion containing 2% SDS, 0.062 M Tris-
HCI, pH 6.8, 0.04% DTT, and 10% glyc­
erin (see Fig. I). 
Antisera. Antibodies to sporozoites were 
produced in rats as well as in rabbits. Three 
rabbits were immunized by interrupted 
biting of mosquitoes infected with P. ber-
ghei in seven sessions spread over an inter­
val of 6 months. The development of 
antibodies against sporozoites was followed 
in the indirect fluorescent assay (IFA), 
using purified sporozoites as slide antigen 
and fluorescein-labeled swine anti-rabbit 
IgG antibodies (Nordic) as a conjugate. The 
eventual titer in the IFA was 1:5120 to 
1:10,240. The animals were bled and the 
sera stored at -20 С. Control rabbit sera 
were developed by similar sessions of bites 
by noninfected mosquitoes. Later four 
Wistar rats were immunized in the same 
way as the rabbits, but under treatment of 
nivaquine 200 mg/liter in the drinking water 
in order to prevent a patent infection. When 
IFA titers were about 1:1280 the rats were 
exsanguinated and sera were stored at -20 
C. Anti-blood schizont sera were obtained 
from rats that had severe blood-induced 
parasitemia. 
RESULTS 
SDS-Gel Electrophoresis of Soiubilized 
Sporozoite Proteins 
lodination of intact Plasmodium berghei 
sporozoites resulted in the labeling of at 
least three surface proteins (Sp) as can be 
seen in the SDS-gel electropherogram 
(Fig. 2). These proteins, present in the 
total-labeled-protein fraction are identified 
by figures related to their apparent molec­
ular weight expressed in kilodaltons, i.e., 
Sp 110, 85, and 53. Minor peaks at 160,000 
and 40,000 daltons could occasionally be 
detected. Labeled material of low molecu­
lar weight runs together with the tracking 
dye (TD); this was not further analyzed. 
Extraction with 1% Triton X-100 solubilizes 
about 70% of Sp 53 and about 40-50% of 
the other proteins as shown in Fig. 2. 
Immunoprecipitation 
Using rabbit anti-sporozoite serum only 
two proteins could be precipitated, namely, 
Sp 110 and Sp 53 (see Fig. 3). Rat antibodies 
against sporozoites precipitated the same 
two proteins (SDS pattern not shown). In­
cubation with control sera from animals 
bitten by noninfected mosquitoes gave no 
precipitation of any of the proteins. Surface 
protein 85 seemed to adhere to the staphy­
lococci because in all the SDS-PAGE pat­
terns it gave rise to a small elevation of the 
number of counts per minute. Noninfected 
mosquitoes were also processed in the same 
way as the infected ones. The labeling of 
those fractions of the Percoli gradient in 
which sporozoites are normally present, re­
sulted in four peaks, but none of these could 
be precipitated with anti-sporozoite serum, 
under the experimental conditions used for 
infected mosquitoes. It appeared from these 
results that Sp 110 and Sp 53 were specific 
sporozoite antigens, however, it was uncer­
tain whether there was cross-reactivity be­
tween these two proteins and antigens of 
blood stages. In order to investigate this we 
incubated Triton X-100-soluble proteins 
with sera from rats with blood-induced par­
asitemia. The anti-blood stage IFA titer of 
these sera with schizonts as slide antigen 
was 3= 1:640. Neither Sp 110 nor Sp 53 were 
precipitated by these sera under the ex­
perimental conditions used. In order to see 
whether the surface protein antigens of 
" immature" (oocyst) sporozoites were 
different from those of "mature" (salivary 
gland) ones, we isolated sporozoites from 
mosquitoes 12 days after the infective blood 
meal. At this stage of development, 
sporozoites are not seen in the salivary 
glands, although the oocysts are filled with 
sporozoites. The isolation procedure as 
well as the labeling was identical to that for 
the mature sporozoites. 
After labeling, solubilization, and S D S -
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FIG. 2. Sodium dodecyl sulfate-Polyacrylamide gel electrophoresis of Triton X-100-solubilized pro-
teins of mature Plasmodium berghei sporozoites. 
PAGE, the immature sporozoites were found 
to have the same three proteins Sp 110, 85, 
and 53 on their surface as the mature ones, 
as can be seen in Fig. 4. Incubation of Triton 
X-100-soluble proteins of these immature 
sporozoites with sera raised against saliva 
stages resulted in the precipitation of Sp 110 
as well as Sp 53. In this respect there was 
no difference between sporozoites isolated 
from mosquitoes 12 and 21 days after the in-
fective blood meal. 
Since the determination of the molecular 
weight by this method includes an error of 
about 5-10% (Lambin 1978), it is possible 
that the fraction Sp 110 is a dimer of Sp 53. 
If, however, these two proteins are truly 
different, it is likely that one is more im-
munogenic than the other and that the 
host's immune system would then respond 
earlier to the stronger antigen. We investi-
gated this by using three serum samples 
collected from one rabbit during the course 
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FIG. 3. Sodium dodecyl sulfate-Polyacrylamide gel electrophoresis of Triton X-100-solubilized 
antigens of the sporozoites of Plasmodium berghei, precipitated with immune serum 
of immunization with sporozoites, each 
serum sample being taken 1 week after a 
booster. Figure 5 shows that antibodies 
against both proteins appeared simulta­
neously. Therefore a difference in the im-
munogenicity between these two could not 
be demonstrated. 
DISCUSSION 
Using the Percoli gradient, suspensions 
that contained large numbers of sporozoites 
were so purified that contaminating mi­
croorganisms did not affect the labeling. This 
method of isolating sporozoites has an ad­
vantage over the dissection of individual 
mosquitoes, because one person can pro­
cess 2000 mosquitoes in about 3 hr. This is 
of importance since the isolation of proteins 
requires the processing of a large number of 
mosquitoes for purifying even a small 
quantity of sporozoite protein. 
We were not successful in our attempt to 
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FIG. 4. Sodium dodecyl sulfate-Polyacrylamide gel electrophoresis of Tnton X-100-solubilized 
proteins of immature sporozoites of Plasmodium berghei. 
use the DEAE column techniques for the 
isolation of sporozoites, as described by 
Moser et al. (1978) and Mack et al. (1978). 
The yield of purified sporozoites by these 
methods was very poor. 
Surface proteins of cells can be radio­
labeled in different ways. Some investi­
gators used nonpermeable radiolabeled 
molecules which bind covalently to free 
functional groups on the boundary of the 
surface proteins (Bretscher 1973; Cross 
1975). A disadvantage of this method is the 
possible alteration of the protein with re­
gard to the tertiary or quaternary structure. 
This can be of great importance in im­
munological reactions. Therefore we chose 
another method described by Phillips and 
Morrison (1971) and modified by Hubbard 
and Cohn (1972). This method is based on 
the covalent binding of radioactive iodine 
atoms to the tyrosine residues of proteins, 
catalyzed by the (nonpermeable) enzyme 
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FIG 5. Sodium dodecyl sulfate-Polyacrylamide gel electrophoresis of Tnton X-100-solubilization 
antigens of sporozoites of Plasmodium berghei precipitated with sera taken from rabbits during the 
course of immunization against Ρ berghei sporozoites. 
lactoperoxidase. Using the latter method, 
surface proteins could be exclusively 
labeled in the case of erythrocytes (Hub­
bard and Cohn 1972), mouse L cells (Hub­
bard and Cohn 1975), and hepatoma tissue 
culture cells (Tweto et al. 1976). Since the 
technique, used in the present study, is 
based on the method of Hubbard and Cohn 
we have assumed this to label only surface 
proteins of sporozoites. 
Recently Gwadzef al. (1979) reported the 
presence of a 41,000-dalton-molecular-
weight protein on the surface of Plas­
modium berghei sporozoites that precipi­
tated with immune serum. This report was 
followed by a publication of Yoshida et al. 
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(1980) that described the development of a 
hybndoma producing monoclonal anti­
bodies against a 44,000-dalton-molecular-
weight surface protein of Ρ berghei sporo-
zoites Mice bearing this hybndoma were 
protected against infections by the homolo­
gous sporozoites 
We are unable to explain why the molec­
ular weight of the functional protein on the 
surface of sporozoites in these studies is so 
different from those demonstrated in our 
study One possible source of variation is 
that the electrophoretic mobility of the 
protein was tested in 10% Polyacrylamide 
gels while we used 7 5% gels. Another 
could be that the solubilization in Triton 
X-100 had influenced the electrophoretic 
mobility in SDS-PAGE The presence of 
another 110,000-dalton-molecular-weight 
protein in our system may be due to the 
higher sensitivity in our detection method 
compared to autoradiography of dried gels 
However, it is still a possibility that the 
Sp 110 is a dimer of Sp 53 In preliminary 
expenments we have been able to separate 
these two proteins after solubilization in 
0 5% sodium desoxycholate and gel filtra­
tion in Sephacryl S200 In these experi­
ments we also found that these separated 
proteins are both precipitable with immune 
serum and SaCI Therefore, we conclude 
that if Sp HOisadimerof Sp53, the former 
should exist in the outer membrane in this 
dimenc conformation and monomenzation 
is not induced by SDS-PAGE procedures 
A somewhat unexpected result was the 
demonstration of the presence of both these 
proteins on the surface of immature sporo­
zoites Nussenzweig et al (1972) reported 
that there was no cross-reactivity in the 
CSP reaction between oocyst sporozoites 
and salivary gland sporozoites Using the 
indirect fluorescent antibody technique 
they demonstrated later a mild positive re­
action of oocyst sporozoites with sera di­
rected against salivary gland sporozoites 
(Nardin el al 1979) With our techniques 
we showed that both proteins on the sur­
face of immature sporozoites are immuno­
logically the same as those on mature spo­
rozoites There might, however, be a differ­
ence in the number of protein molecules 
on the surface of individual sporozoites as 
Dubremetz el al (1979) demonstrated using 
freeze-fracture studies These investiga­
tions indicated that there were far more in-
tramembranous particles on the inner frac­
ture face of the outer membrane in salivary 
gland sporozoites than in oocyst sporozo­
ites of Ρ yoelu 
The two proteins we have demonstrated 
on the surface of the sporozoites do not ap­
pear to be involved in the serological cross-
reactivity of sporozoites and blood forms 
(Golenser et al 1978) which is known to 
disappear after glutaraldehyde fixation of 
the sporozoites (Nardin et al 1979) 
Since indications are present that the 
surface proteins of Plasmodium sp sporo­
zoites are functional in inducing protection 
(Polocnjak et al 1980), further research will 
be directed to the determination of the phys-
icochemical properties of these proteins 
which could result in the isolation and puri­
fication of one or both proteins 
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Two immunologically significant proteins, Sp53 and Sp 110, have been isolated from the sporozoites 
of Plasmodium berghei ANKA strain using different extraction procedures In gel filtration studies 
the physicochemical characteristics of Sp53 and Spi 10 appeared to be somewhat different Both 
polypeptides could be purified using Sephacryl S300 column chromatography The possible relation­
ship of both Sp53 and SpllO with sporozoite proteins described by other investigators is discussed 
Key words Plasmodium berghei, Sporozoites, Rodent malaria, Surface labelling, Membrane protein 
purification. Surface sporozoite proteins 
INTRODUCTION 
Sporozoites, the infective stage of the malaria parasite, are powerful tmmunogens 
when administered under the appropriate conditions [1,2] This immunity is characteriz­
ed by a stage and species specificity Protective anti-sporozoite immunity has been induc­
ed against different parasite species in rodents, in monkeys and in human volunteers 
(reviewed in [3]) By a method of radiolabelhng of intact sporozoites of Plasmodium 
berghei ANKA [4] and NK 65 strams [5] it was possible to detect stage specific proteins 
on the surface of these sporozoites The antigenic role of these proteins was demonstrated 
using immune sera [4, 6] Yoshida and coworkers have developed monoclonal antibodies 
against the surface protein of Ρ berghei NK 65 sporozoites (Pb44)[7] Pb44 appeared 
to be involved uv-the induction of protective antisporozoite immunity in Ρ berghei [8] 
In a previous paper [4] we reported on the presence of these three proteins on the 
surface οϊΡ berghei ANKA sporozoites, namely SpllO, Sp85 and Sp53, with molecular 
weights of 110 kilodaltons (kDa) 85 and 53 kDa respectively SpllO and Sp53 were 
* Present address Blood Transfusion Service, University Hospital, Geert Grooteplem Zuid 10, 6500 
HB Nijmegen, The Netherlands 
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shown to react specifically with antibodies produced in rabbits and rats immunized with 
intact sporozoites [4]. 
In this study we have investigated some of the physico-chemical characteristics of 
these two proteins. These investigations have resulted in the development of techniques 
for the purification of both proteins at an analytical scale. 
MATERIALS AND METHODS 
Isolation of sporozoites. Sporozoites of P. berghei ANKA were harvested from Anopheles 
stephensi mosquitoes as described previously [4]. 
Radiolabelling of sporozoites. Purified sporozoites were labelled with iodine 125 by two 
different methods: 
(i) using lactoperoxidase, based on the procedure of Hubbard and Cohn [9] and 
described in detail in [4], 
(ii) using lodogen as described by Markwell and Fox [10]. The lodogen method is 
summarized here. 
1 ml of lodogen solution containing up to 100 pg of 1,3,4,6-tetrachloro-3,6-diphenyl-
glycoluril (lodogen) (Pierce Chemicals) in CHCI3 was introduced into a glass tube with 0.6 
cm internal diameter. The chloroform was evaporated by the influx of N2 gas or under 
vacuum in a desiccator. The glass tube was thus coated with reagent. Up to 10e sporo­
zoites were suspended in 1 ml isotonic phosphate buffer (PB 310) pH 7.2 [11] and added 
to the lodogen-coated tubes. 100—500 дСі , 2 5 I " (Amersham) (carrier-free, specific 
radioactive concentration 100 mCi ml - 1) was also added. The reaction was allowed to 
continue for 10 min at room temperature. The iodination was stopped by removing the 
sporozoite suspension from the reaction vessel. The sporozoites were pelleted by centrifu-
gation for 4 min at 18 000 X g using an Heraeus Christ Haemofuge adapted for Eppen-
dorf cups and washed four times with PB 310 to remove non-bound iodine. Using the 
same method it was possible also to label soluble proteins, previously extracted from 
sporozoites. In this case non-bound iodine was removed by extensive dialysis. 
Solubilhation of sporozoite proteins. Sporozoites were subjected to a protein extraction 
procedure before or after labelling. All reagents used were of analytical grade purity. 
100 μΜ phenylmethylsulphonyl fluoride (Merck) was added to all protein solutions 
to prevent proteolytic cleavage of the extracted proteins [12]. The relative amount 
of protein solubilized was determined using sodium dodecyl sulphate-polyacrylamide gel 
electrophoresis (SDS-PAGE) of the labelled samples followed by counting of the radio­
activity in the gel slices using a LKB-Wallac gamma scintillation counter. 
SDS-polyacrylamide gel electrophoresis. Protein samples were mixed with equal volumes 
of a solution containing 2% SDS, 0.062 M Tris-HCl, pH 6.8, 0.04 M dithiothreitol, 10% 
glycerin (all purchased from Merck) and bromophenol blue added as a tracking dye. 
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This mixture was boiled for three minutes, layered on top of a 7.5% acrylamide gel rod, 
containing 0.1% SDS and electrophoresed at 3mA/rod until the tracking dye had run 
over the length of the gel. All further experimental conditions were as described by 
Laemmli [13]. Molecular weight markers (Boehringer Mannheim) were run on a separate 
gel in every experiment. 
Gel filtration of sporozoite proteins. Separation of solubilized labelled proteins according 
to their molecular size was performed in Sephacryl S300 (Pharmacia Fine Chemicals) 
and in Biogel A-1.5M (Bio-Rad Labs.) using different buffers. All columns (Pharmacia) 
were calibrated using up to seven different macromolecules (Combithek from Boehringer 
Mannheim) with molecular weights ranging from IO3—10' Da. Columns were repacked 
if calibration was not satisfactory. In all experiments the columns were run at room 
temperature or cooled with running water when possible. Fractions of 0.5 ml were col­
lected using a LKB—Redirac. Up to 100 μΐ per fraction was analysed for labelled proteins 
on SDS-PAGE. 
RESULTS 
Radiolabelling of sporozoites. Since the labelling method described earlier [4] needed 
the introduction of foreign proteins, Le. lactoperoxidase and glucose oxidase, we also 
applied the lodogen method for radio-iodination. 
Aliquots of sporozoites were labelled in vials containing 0, 1, 5, 10, 25, 50 of 100μg 
lodogen and 100 ßCi 1 2 51". The iodinated proteins were analysed by SDS-PAGE. Fig. 1 
shows the SDS-PAGE pattern of the proteins labelled by this method using 100 μg 
lodogen. Only one protein in the range of 2 X 104-2 X IO5 Da could be labelled namely 
Sp53. 
Sobibilization of sporozoite proteins. Initially we have investigated which surface proteins 
could be solubilized by specific extraction procedures. Different procedures were used of 
which one was selected and tests were done to determine whether internal proteins were 
also extracted which could contaminate the Final solution of surface proteins. The 
amount of labelled protein was calculated from the radioactivity, in cpm, found beneath 
a peak in the SDS-PAGE pattern. Table I shows the comparison of nine different extrac­
tion procedures to solubilize either Spi 10 or Sp53 from intact labelled sporozoites. 
Extraction using lOmM Tris/0.5 mM MgCl2/0.5% Triton X-100, pH 8.0, solubilized 
Sp53 best. In some cases over 90% of Sp53 was solubilized using this method. About 
50% of Spi 10 could also be extracted by this procedure. The use of Triton is preferential 
over deoxycholate since the latter can only be used at a pH higher than 7.5. High ionic 
strength (2 M NaCl) does not release any labelled protein nor does 10 mM Tris without 
any detergent added. The use of 6 M urea resulted in the extraction of appreciable 
amounts of different proteins but since urea can cause severe denaturation, this method 
was not further pursued. 
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Fig. 1. SDS-PAGE of ' " I-labelled sporozoite surface proteins using lodogen. 
TABLE I 
Solubilization of labelled sporozoite proteins 
Solubilization procedure (18 h at 4°C) Solubilized proteins 
SpllO Sp53 Others 
1. 10 mM Tris, pH 7.2 
2. 10 mM Tris/1% Triton, pH 7.2 
3. 10 mM Tris/1% Triton, pH 8.0 
4. 10 mM Tris/0.5 mM MgCl,/0.5% Triton, pH 8.0 
5. 10 mM Tris/0.5% deoxycholate, pH 8.0 
6. SO mM Tris/125 mM NaCl, pH 8.0 
7. 50 mMTris/125 mM NaCl/0.5% deoxycholate, pH 8.0 
8. 10 mM Tris/2 M NaCl, pH 8.0 
9. 6 M Urea 
The amount of protein solubilized as a result of a specific extraction procedure is expressed as the 
percentage cpm of the total number of cpm present in that protein in the starting material -, 0-30%; 
t, 30-60%;+, 60-90%;++, > 90%. 
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Table II shows the results of experiments in which solubilization was carried out prior 
to radiolabelling of proteins. In this table three extraction procedures are compared with 
one another. Procedure 1, the best solubilizing agent for Sp53, is compared with a buffer 
known to solubilize the very hydrophobic 'band 3' protein from human erythrocytes, 
procedure 2 [14]. Aliquots of sporozoites were incubated for 2 h at 0 eC in the buffer, 
in the presence of phenylmethylsulfonyl fluoride. The non-solubilized material was 
pelleted by centrifugation for 1 h at 18 000 X g at 40C. The supernatant was labelled 
using the lodogen method. A sample of the labelled material was analysed for the pre­
sence of protein using SDS-PAGE. The yield of the relevant proteins was better when 
Tris-buffered Triton was used rather than the phosphate-buffered Triton. 
When sporozoites were sonicated in 10 mM Tris/0.5 mM MgClj, pH 8.0 (procedure 3), 
Spi 10 was released even better than SpS3. As expected, sonication abo released other 
proteins. These proteins however did not contaminate the final purified fractions as will 
be shown below. 
Gel fdtration. In view of the strong denaturation of proteins by SDS-PAGE, column 
chromatography was also used for the assessment of the size of the relevant proteins 
in solution. Effects of the presence of Triton X-100 and high or low ionic strength on 
their molecular size were investigated. Table 01 gives the results of different gel filtra­
tion experiments in Sephacryl S300. It shows that an increase in the ionic strength of the 
elution buffer (experiments A and B) results in an improved recovery of both proteins. 
A further increase [(200 mM Tris/5 mM MgCl2/0.5% Triton X-100, pH 8.0)/0.5 M NaCl] 
did not improve the result (not shown). The necessity for the presence of Triton X-100 
in the elution buffer was clearly demonstrated in experiment С Neither Sp53 nor Spi 10 
were recovered by the use of 10 mM Tris/0.5 mM MgClj buffer (pH 8.0), nor by sub­
sequent use of 0.2 M Tris/5 mM MgCl2 buffer (pH 8.0), but the addition of 0.5% Triton 
TABLE Π 
Solubilization of sporozoite pioteins prior to labelling 
Solubilization procedure Solubilized proteins 
Spi 10 Sp53 Others 
1. 10 mM Tris/0.5 mMMgCl,/0.5% Triton, pH 8.0, 2 hat 0oC ± + ± 
2. 18 mM phosphate/0.5% Triton, pH 8.0,2 h at 0°С - ι 
3. Sonication in 10 mM Tris/0.5 mM MgCl,, pH 8.0, cen-
trifugedfor 15 minat 18 0 0 0 X Í ++ + + 
The amount of protein solubilized as a result of a specific extraction procedure is expressed as the 
percentage cpm of the total number of cpm present in that protein in the starting material Symbols 
as for Table I. 
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TABLE UI 
Gel nitration of '" I-labelled sporozoite proteins 
A 
B. 
С 
D. 
Labelling 
procedure 
LPOa 
LPO3 
LPOa 
lodb 
Column 
dimensions (cm) 
0.9 X 30 
0.9 X 30 
0.9 X 30 
1.5 X 30 
Elution buffer0 
50TTX 
200 TTx 
M O T 
2.200 Τ 
3.200 TTx 
100 Τ 
% ratio eluted/startd 
Sp53 (AMW)e 
7 (> 150 kDa) 
70(>150kDa) 
< 1 
< 1 
50 (> 150 kDa) 
2 ( F 0 ) 
SpllO(AMW) 
< 1 
50 (> 150 kDa) 
< 1 
< 1 
40 (> 150 kDa) 
20 (110 kDa) 
Intact sporozoites were labelled using the lactoperoxidase method. Proteins were subsequently 
extracted using buffer 4 from Table I. 
Sporozoites were sonicated (procedure 3, Table II); the soluble proteins were subsequently labelled 
using the lodogen method. 
Buffers used were: 
50 TTx: 50 mM Tris/5 mM MgClj/O.SSb Triton X-100 (pH 8.0) 
200 TTx: 200 mM Tris/5 mM MgCl,/0.5% Triton X-100 (pH 8.0) 
10 Τ : 10 mM Tri^ O.5 mM MgCl, (pH 8.0) 
200 Τ : 200 mM Tris/5 mM MgCL, (pH 8.0) 
200 TTx: 200 mM Tris/5 mM MgCl,/0.5% Triton X-100 (pH 8.0) 
100 Τ : 100 mM Tris/5 mM MgCl, (pH 8.0). 
This ratio was calculated Ъу comparing the quantity of a specific protein (in cpm) before gel 
filtration with that in the eluting fraction. The number of cpm was determined by SDS-PAGE 
analysis. 
AMW: Apparent molecular weight (in kDa) is assessed on account of the elution of this fraction 
as related to that of marker proteins. 
X-100 to the latter buffer resulted in the elution of 50% of the relevant proteins present 
in the starting material. In experiment D proteins solubilized by sonication were sub­
sequently labelled and subjected to chromatography in the absence of Triton X-100. 
Sp53 was eluted at low concentration in the void volume while Spi 10 was eluted in 
relatively small yield but as a 100—150 kDa protein. 
Purification of Sp53 and SpllO. Several experiments with fresh and frozen sporozoites 
have been done to purify Sp53 and SpllO. Proteins were extracted from intact, labelled 
sporozoites using procedure 4 in Table I. The solubilized proteins were loaded and 
chromatographed on a 1.5 X 90 cm column packed with Sephacryl S300. The elution 
buffer consisted of 0.2 M Tris/5 mM MgClî/0.5% Triton X-100 (pH 8.0). The flow rate 
was 2 ml h - 1 ,1 .5 ml fractions were collected and analysed using SDS-PAGE. Fig. 2 shows 
the elution pattern of this column. Proteins Sp53 and SpllO could be detected in frac-
tions 76-84 and not in the fractions with the highest radioactivity (i.e. fractions 8 5 -
100, which contained mostly less than 20 kDa material). The insets A and В show the 
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Fig. 2. Elution profile of column chromatography of labelled sporozoite proteins. Sporozoites were 
intactly labelled using the LPO method. Labelled proteins were extracted using 10 mM Tris/O.S mM 
MgClj /0.5% Triton, pH 8.0, loaded on a 90 X 1.5 cm column packed with Sephacryl S300 and chro-
matographed using 0.2 M Tris/5 mM MgClj/0.5% Triton, pH 8.0. The column was calibrated using 
Blue Dex&an (BD) 2000 kDa, ferritin (FER) 450 kDa, aldolase (ALD) 158 kDa and ovalbumin (OA) 
45 kDa. Inset A : SDS-PAGE of fraction 78 (arrow A). Inset В : SDS-PAGE of fraction 82 (arrow B). 
SDS-PAGE patterns of fractions 78 and 82, respectively. Sp53 and Spi 10 could be 
eluted in different fractions from this column. Both proteins seemed to be aggregated in 
oligomeric complexes. The molecular weights that correspond with the fractions at which 
Spi 10 and Sp53 were eluted, were 300 and 250 kDa, respectively. 
The procedure for the purification of relevant proteins from frozen sporozoites 
was as follows. Sporozoites which had been stored at -70"C were sonicated 4 X 10 s 
at 0oC in 10 mM Tris, pH 8.0. The soluble fraction was labelled and dialyzed against 
0.2 M Tris/5 mM MgCl2> pH 8.0. After addition of 0.5% Triton X-100 it was chromato-
graphed under experimental conditions identical to those described above. Fig. 3 shows 
the SDS-PAGE pattern of a fraction of this elution. Sp53 was isolated in a pure form 
since no other labelled material, high or low molecular weight, was detectable in this gel. 
Spi 10 however, although present in the starting material, could not be eluted from this 
column. Replacement of Sephacryl by Biogel A1.5M could not improve the recovery of 
the latter protein, although less non-specific radioactivity was retained by this gel. 
Antigenicity of Spi 10 and Sp53. After purification by either method both Sp53 and 
Spi 10 were precipitated by anti sporozoite serum collected from rabbits repeatedly 
exposed to bites by P. èe/ytei-infected mosquitoes [4] and by hybridoma 3D11 provided 
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Fig. 3. SDS-PAGE of one fraction from a 90 X 1.5 cm column packed with Sephacryl S300. Soluble 
spoiozoite proteins released by sonication were labelled using lodogen and loaded on the column. 
Following chromatography the fractions were analysed using SDS-PAGE. 
by Professor Ruth Nussenzweig. This hybridoma produces monospecific antibodies 
directed against Pb44, the surface protein of P. berghei sporozoites (NK65 strain) as 
described by Yoshida et al. [7]. Also the fractions 85-100 (Fig. 2) were analysed for the 
presence of antigenic polypeptides. No radioactivity however, could be precipitated from 
these fractions using immune rabbit serum or 3D11 antibodies. 
DISCUSSION 
Previously we reported that three surface proteins of/*, berghei (ANKA) sporozoites 
could be labelled by the use of a modified Hubbard and Cohn procedure [4]. Here we 
have used the lodogen method to label soluble proteins in the absence of peroxide and 
foreign proteins. The use of this method also resulted in a good labelling of the surface 
proteins of intact sporozoites, although only Sp53 was labelled in this way. An explana­
tion for the different results obtained by the use of both methods could be that in the 
lactoperoxidase method the outer membrane was damaged by free hydrogen peroxide. 
Thereby it could have caused the labelling of 'internal' proteins Sp85 and Spi 10, 'internal' 
in this respect could also mean anchored in the inner half of the lipid bilayer of the outer 
membrane. In two experiments we have reduced the quantity in the labelling buffer of 
glucose (the substrate for the peroxide synthesizing enzyme glucose oxidase) from ΙΟμιηοΙ 
56 
to 0.5 μπιοΐ. This resulted in a relatively better labelling of Sp53 whilst the labelling of 
Spi 10 was markedly reduced and Sp8S could not even be detected (unpublished results). 
This might mean that Sp53 is the only protein present on the surface of sporozoites of 
P. berghei (ANKA strain). 
From the gel filtration experiments the following conclusions can be drawn: Sp53 
is relatively hydrophobic and needs the presence of a detergent to be soluble as a 250 
kDa complex. In the absence of Triton X-100 a reversible process of aggregation occurs. 
Also the ionic strength of the buffer seems to influence the state of aggregation of Sp53 
or its possible interaction with column material. The protein was released in aggregated 
form from the surface of the sporozoites by sonication in a buffer of low ionic strength 
without Triton X-100. 
Spi 10 appeared to have more hydrophilic characteristics. It is easily solubilized by 
sonication in buffer without detergent, it seems not to be aggregated in 0.1 M Tris/5 mM 
MgCl2 at pH 8.0 and has a molecular weight of 110 kDa (Table Ш). When it is extracted 
from sporozoites using Triton X-100 the protein forms a complex with a molecular 
weight of 300 kDa. 
On account of their reaction with immune sera as well as monospecific antibodies, 
Spi 10 and Sp53 are indistinguishable. This could mean that Spi 10 is a dimer of Sp53. 
When and how dimerization takes place is still uncertain. Dimerization might occur in 
the sporozoite itself during transport of Sp53 to the outer membrane. Dimerization might 
also occur during the purification procedure. However, Spi 10 is not cleaved into two 
Sp53 units by the presence of Triton X-100 or SDS+dithiothreitol. The disappearance 
of Spi 10 during column chromatography of proteins that were released by sonication is 
difficult to explain. Perhaps the addition of Triton after sonication caused passive adhe­
sion of Spi 10 to subcellular particles such as nucleoli or minor fragments, which might 
have been present in the 'soluble' fraction. 
Recently Yoshida and coworkers reported on the biosynthetic labelling of P. berghei 
NK65 sporozoites [15]. Using [x S]methionine, no dimer of their surface protein Pb44 
could be detected in their experiments. Two polypeptides, however, with molecular 
weights of 54 and 52 kDa were labelled, namely Pb54 and Pb52 respectively. These two 
proteins were not labelled using a surface labelling technique. Although it might appear 
that our surface protein Sp53 bears a close relationship to Pb54 and Pb52 on account of 
their molecular weights, this cannot be true since the latter two are internal proteins. If 
Sp53 was an internal protein it would be labelled by surface labelling techniques only 
if the true surface membrane of the sporozoites had been lost during manipulations. 
Evidence for the integrity of these sporozoites comes from the following observations. 
Suspensions of sporozoites purified using the Percoli procedure have been used in studies 
on developing exoerythrocytic forms and caused normal infections [16], although infect-
ivity titration has not been carried out. Another proof of the vitality of the Percoli 
purified sporozoites was the observation that about 50% of these sporozoites gave positive 
CSP reactions using monoclonal 3D11 and immune rat serum. Since sporozoites which 
have lost their surface coats are probably not infective and will not give positive CSP 
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reactions, we believe that Sp53 is a true surface protein Even if only a part of the sporo-
zoites would have lost its surface coat, we would have been able to label and immuno-
precipitate small amounts of a polypeptide with a molecular weight close to 44 kDa 
This however, was never found 
Differences in molecular weight found for both surface proteins Pb44 and Sp53 
might be due to the use of different strains of Ρ berghet or to the difference in technical 
procedures Collaborative experiments are planned for the nearby future in order to clear 
the issue. 
The purification of Sp53 and Spi 10 was shown to be possible using gel filtration. 
Using long columns and slow flow rates a reproducible purification of both proteins 
could be obtained. It should be emphasized that the frozen sporozoites used to perform 
some of the experiments had been stored for over two years at -70 oC The proteins were 
still antigenic in that they reacted with immune sera as well as with monospecific anti­
bodies from 3D11 It is therefore possible to use sporozoites stored in this way to obtam 
purified preparations of Sp53 and Spi 10 for in vivo studies on anti-sporozoite immunity. 
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SUMMARY 
Sp53, the protein present on the surface of Plasmodium berghei 
sporozoites (4,5), which can be isolated by selective solubilization and 
gel filtration, was further purified by immuno-affinity chromatography 
using monoclonal antibody (3D11) coupled to Sepharose 4B. This antibody, 
which was produced against sporozoites of P.berghei (NK65) (6), had 
previously identified the protective surface antigen (Pb44) and its 
intracellular precursors (Pb52 and Pb54) of these sporozoites (11). The 
purified fraction from sporozoites of the ANKA strain contained 
practically pure Sp53, as determined by SDS-PAGE followed by 
autoradiography of the labelled proteins. This material was used to 
investigate the conditions that influenced the molecular weight 
determination of Sp53, especially since there was a discrepancy with 
that of Pb44 (6). Our present results indicate that the acrylamide 
concentrations have caused the differences in molecular weight 
determinations. Simultaneous electrophoresis of iodinated and purified 
Sp53 (ANKA), and a metabolically-labelled sporozoite extract of 
P.berghei (NK65) on a 10% acrylamide slab gel indicated very similar 
electrophoretic mobilities for these two proteins, which also do share 
the same epitope. 
INTRODUCTION 
Immunization studies using intact malarial sporozoites have shown 
that this stage can be used to induce protection (1,2). The protein 
covering the surface of the sporozoite seems to play a major role in 
this protection as has been shown for the Plasmodium 
berghei-(NK65)-mouse model (3). This protein (Pb44) was shown to have a 
molecular weight (MW) of about 44 kilodaitons (kD) as determined by 
SDS-polyacrylamide gelelectrophoresis (SDS-PAGE) using a 10% running 
gel. In previous papers we have reported the presence of a similar 
protein, namely Sp53, on the surface of sporozoites of P.berghei (ANKA) 
and a method to purify this protein using gel filtration techniques (4, 
5). Sp53 was shown to react with monoclonal antibodies from hybridoma 
3D11, which was originally developed against Pb44 (5, 6) and which was 
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provided by the courtesy of Prof. R.S. Nussenzweig. 
In this study we have applied the same monoclonal antibodies for 
the purification of Sp53 using iumuno-af finity chromatography. The 
purified antigen has been used to study the discrepancy found in the 
molecular weight between Sp53 (53kD) and Pb44 (44kD). This is not only 
important for our appreciation of the actual molecular size of the 
proteins but also for the relationship between Sp53 and Pb44 and the 
precursors of Pb44 i.e. Pb52 and Pb54 (11). The present experiments 
demonstrate that the previously described difference in MW was in fact 
caused by technical artefacts. Sp53 is therefore considered to be 
identical to Pb44, i.e. the protective surface antigen of P.berghei 
sporozoites, and not to its intracellular precursors. 
MATERIALS AND METHODS 
Purification and radioiodination of sporozoites. 
P.berghei (ANKA) sporozoites were harvested from infected Anopheles 
Stephensi mosquitoes as described previously (4). Ten to 50 million 
125 purified sporozoites were labelled with Iodide (Amersham) using the 
lactoperoxidase method (4). 
P.berghei (NK65) sporozoites were recovered from A.stephensi 
35 
mosquitoes and metabolically labelled with S-methionine as described 
(11). 
Monoclonal antibody 3D11. 
The hybridoma, secreting monoclonal antibody 3D11, was produced by 
earlier described methodology (6). Briefly, adult Balb/c were immunized 
by multiple bites of irradiated mosquitoes infected with sporozoites of 
the NK65 strain of P.berghei. Four days after the last immunizing dose, 
when high levels of antisporozoite antibodies were detectable, immune 
spleen cells were recovered and fused with NS-1 plasmacytoma cells. 
Production and purification of 3D11 was as described (3). 
3D11 Immuno-affinity chromatography. 
Ascitic fluid containing monoclonal antibodies from hybridoma 3D11 
was dialysed against 0.15M NaHCO, pH 8.3 (coupling buffer), and allowed 
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Co react with CNBr-activated Sepharose 4B (Pharmacia) according to the 
prescribed instructions. The coupling efficiency was better than 95% as 
determined by O.D. measurements at 280 nm. Two ml of the coupled gel 
were poured into a plastic column (lOmm in diameter) with a nylon gel 
support. Before use the affinity column was washed with 1 volume of 
0.05M citric acid-0.5M NaCl-0.5%TritonX100 pH 2.6 (elution buffer) 
followed by 10 vols of 0.2M Тгів-ЗпМ MgCl2-0.5M NaCl-0.5% TritonXlOO pH 
8.0 (running buffer). Sporozoite proteins were extracted from purified, 
125 
I-labelled sporozoites and chromatographed on Sephacryl S300 (5). The 
fractions containing Sp53 were pooled and adjusted to 0.5M NaCl and 
three times applied to the affinity column (at room temperature). The 
column was subsequently washed with 20ml of running buffer. Material 
specifically retained by the column was released using 1ml of elution 
buffer (see above) followed by 1ml of running buffer. The solution was 
immediately adjusted to neutral pH by addition of a few drops IM Trie 
after which it was dialysed against 50mM Tris-0.5%TritonX100 pH 8.0. 
SDS-polyacrylamide gel electrophoresis (SDS-PAGE). 
SDS-PAGE was carried out in 0.7mm slab gels using the Laemmli 
buffer system (5,7). Acrylamide and Ν,Ν-methylene-bisacrylamide were 
purchased from BDH Labs (electrophoresis grade). Uniform acrylamide gels 
were pre-electrophoresed for 60 min then run at 25mA per gel constant 
current. Linear gradient gels were made from 4% and 22.5% acrylamide 
stock solutions (2.7% crosslinking) in a Pharmacia gradient mixer. The 
22.5% solution contained 20% glycerol to stabilize the gradient. 
Calibration proteins were obtained from Bio-Rad Labs consisting of 
myosin, 200kD; beta-galactosidase, 116kD; Phosphorylase В, 92kD; bovine 
serum albumin, 66kD; ovalbumin, 45kD; carbonic anhydrase, 31kD; soybean 
trypsin inhibitor, 21kD; lysozyme, 14kD. Autoradiography of dried gels 
was performed at -70oC using Kodak XAR5 film and intensifying screens. 
For comparison of the electrophoretic mobilities of Sp53 and Pb44, 
me tabolically-labe lied extract of P.berghei sporozoites was 
immunoprecipitated with monoclonal antibody 3D11. Simultaneous SDS-PAGE 
of Sp53 and Pb44 was carried out in a slab gel using 3% acrylamide for 
the stacking gel and 10% for the separation gel (11). 
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Figure 1. Autoradiogram of SDS-PAGE in 7.5% acrylamide gel. Lane A, 
I-labelled Sp53 purified by gelf iltration and IAC. Lane B, Crude 
125 
extract of I-labelled sporozoite proteins prior to purification. 
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RESULTS 
Itnmuno-affinity chromatography (IAC). 
When pooled fractions from the Sephacryl S300 column were applied 
to the 3Dll-Sepharose practically all radioactivity bound to the 
affinity column. This bounded material could again be released totally 
by the eluting buffer (pH 2.6). Figure 1 lane A shows the SDS-PAGE 
pattern of the IAC-purified fraction. The film illustrated was 
deliberately overexposed in order to visualize any contaminating 
labelled proteins. This material (figure 1, lane A) was purified from 
the crude extract shown in the adjacent lane B. It clearly demonstrates 
that all contaminating bands present in the original material have been 
removed by the purification procedure applied. If, however, the crude 
extract was directly applied to IAC, without being submitted to gel 
filtration, the amount of non-specific binding radioactivity was very 
high, whereas the yield of Sp53 was very poor (<10%). Most of the counts 
were irreversibly bound to the column. 
Migration of Sp53 and Pb44 in SDS-PAGE. 
At different acrylamide concentrations in uniform gels Sp53 
migrated at different positions relative to the marker proteins as 
illustrated in figure 2. Sp53 appeared to run relatively faster with 
increasing acrylamide concentration. Its apparent molecular weight (AMW) 
varied from 46kD at 10Z and 53kD at 7.5% to 57kD at 6% acrylamide. 
Omission of pre-electrophoresis (figure not shown) resulted only in a 
higher mobility of all proteins but not in differences in AMW of Sp53 
compared to the pre-electrophoresed gels. Figure 3 shows the position of 
Sp53 in a 4-22.5% acrylamide gradient gel. This gel demonstrated a 
linear relationship between migrated distance and Log (MW) from 14-200kD 
for the calibration proteins (correlation coefficient R=0.98). Using 
regression-line-fitting the AMW for Sp53, on the gradient gel, was 
determined as being 48kD. 
When purified iodinated Sp53 and a metabolically-labelled, 
immunoprecipitated extract of sporozoites of P.berghei were 
simultaneously electrophoresed on a 10% acrylamide gel, the AMW of Sp53 
was similar to but slightly greate- than that of РЬ44 (Sp53 » 45kD, Pb44 
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Figure 2. SDS-PAGE of pur i f ied I - l a b e l l e d Sp53 in gels with 
d i f f e r e n t acrylamide c o n c e n t r a t i o n s . Gel A, 105! acrylamide, gel B, 7.5% 
acrylamide, gel C, 6% acrylamide. Lanes 1,2,5,6 of every gel show 
Coomassie B r i l l i a n t Blue-stained marker p r o t e i n s . Lanes 3 and 4 
represent the autoradiogram of Sp53. 
6* 
А В 
M16 
с/· 92 
ІЕЫЕЕН- RR 
S p 5 3 - · ·
 mÊ^m_ и 5 
12S 
Figure 3. SDS-PAGE of purified I-labelled Sp53 in linear 
gradient gel of 4-22.5% acrylamide. Lane A, autoradiogram of Sp53, lane 
B, Coomassie Brilliant Blue-stained marker proteins. 
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- 44kD). 
DISCUSSION 
The molecular size of proteins can be assessed by a number of 
different methods like analytical ultracentrifugation, gel filtration 
techniques, or SDS-PAGE. In all methode the outcome may be influenced by 
the presence of other contaminating material like proteins, lipids or 
carbohydrates. We have therefore purified the protein of our studies to 
the highest possible grade, using gel filtration in Sephacryl S300 
followed by IAC. Affinity chromatography in general can be a powerful 
tool in the final purification of a range of substances like enzymes (8, 
9), glycoproteins (10), and antigens (12). For the latter application 
(IAC) immobilized immunoglobulins can be used. IAC, however, often 
causes practical problems. These are mostly due to the uncontrollable 
binding conetant(affinity) of the antibody for the antigen. Very high 
affinity results in irreversible binding so that the recovery is 
negligible. Polyvalent serum contains antibodies with different affinity 
for the antigen, which might result only in a partial release of the 
antigen under moderate dissociating conditions. Monoclonal antibodies, 
however, bind to a single epitope of the antigen and all molecules have 
the same affinity for that epitope. The binding constant, however, 
should be high enough to withdraw the protein from the solution and low 
enough to release it under moderate perturbing conditions. The 
experiments described here show that 3D11 antibodies can be succes fully 
applied for the purification of Sp53 by LAC, provided Sp53 is 
pre-purified on Sephacryl S300. It should be noted, however, that 3D11 
was raised against sporozoites of P.berghei NK65 whereas Sp53 was 
isolated from P.berghei ANKA strain. The use of a heterologous antibody 
might have been an additional factor in the good yield of Sp53 obtained 
from the affinity column. This supposition, however, is not yet 
supported by further experimental evidence. 
Another aspect favouring the use of IAC is the effective 
concentration of the protein solution, which is dramatically reduced 
during gel filtration. We could concentrate the solution up to ten times 
without losing any significant amout of material. The purity of the 
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Figure 4. Comparison of electrophoretic mobilities of purified Sp53 
125, 
and Pb44 run simultaneously in 10% acrylamide gel. Lane A, 
125 
marker proteins, Lane B, 
and IAC. Lane C, 
I-labe lied 
I-labelled Sp53 purified by gel filtration 
extract of P.berghei (NK65) sporozoites 
35 . . ~ 
metabolically-labelled with S-methionine and precipitated with 
monoclonal antibody 3D11. 
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final preparation could only be checked by autoradiography of labelled 
proteins. Staining with silver or coommassie brilliant blue did not show 
significant amounts of material. Labelling of proteins after 
purification did not result in additional bands on SDS-PAGE. In most 
experiments little or no SpllO, about which we reported in ref. 4 and 5, 
was detectable by SDS-PAGE and autoradiography. The method of 
radio labe Hing (4, 5) rather the purification procedure might have 
caused this. 
The purified material has been used to clarify the issue of the 
molecular weight of the sporozoite envelope protein (4, 5, 6) and of the 
relationship of Sp53 with Pb44 and its intracellular precursors Pb52 
and/ or Pb54 (11). In our studies (4, 5) separations using SDS-PAGE were 
done in 7.5% acrylamide gels, whereas Yoshida et al.(6, 11) used 10% 
gels. Indeed, when both Sp53 (ANKA) and S-methionine labelled extract 
of P.berghei (NK6S) which had been iramunoprecipitated with monoclonal 
antibody 3D11 were subjected to SDS-PAGE using a 10% acrylamide running 
gel, Sp53 and Pb44 showed almost identical electrophoretic mobilities. 
We believe the minor difference in apparent molecular weights (Sp53 • 
45kD vs Pb44 " 44kD) to be artefactual and a consequence of the elution 
of solubilized Sp53 from the affinity column in the non-ionic detergent 
Triton X100 prior to SDS-PAGE. 
Anomalous behaviour of proteins in SDS-PAGE has been described for 
intrinsic membrane proteins like rhodopsin (13) and glycoproteins like 
glycophorin (14). The AMW for rhodopsin varied systematically from 42kD 
in 4% acrylamide to 32kD in 10% gels. The investigators took this 
protein as a model to derive a more general application of SDS-PAGE in 
MW determination. Using extrapolation to 0% acrylamide by means of 
Ferguson plots they calculated an AMW for rhodopsin of 30kD. Applying 
the same technique to Sp53 its AMW would be 34kD. Recently, however, the 
true MW of rhodopsin has been determined as being 40.8kD on basis of its 
amino acid sequence (15), which demonstrates that the Ferguson plot 
technique does not provide the solution for the described problem. 
Lambin (16) and Poduslo (17) used gradient gels, which demonstrated a 
linear relationship between the mobility and the log(MW) of 
water-soluble proteins and glycoproteins. For intrinsic proteins, 
however, molecular weight determination using SDS-PAGE is still very 
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uncertain and depends entirely on the nature of the individual protein 
(18). 
It will be clear that reporting about the MW of a protein from 
SDS-PAGE in uniform acrylamide gels can be very erroneous. This is even 
more valid for intrinsic membrane proteins. Comparison of molecular 
weights of antigens of strains or species of parasites determined by 
various investigators using SDS-FAGE in uniform acrylamide gels is 
therefore difficult and can be misleading. A standardization of 
techniques such as the use of gradient gels or the use of identical gel 
concentrations would be preferable. In the final analysis, precise 
determination of molecular weights of parasite antigens will result from 
amino acid sequencing of these proteins. 
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SUMMARY 
Immunization using malaria eporozoites can induce hundred percent 
protection against a subsequent infection with this stage. The 
application of purified sporozoite proteins as an immunоgen, however, 
has not yet been pursued by other investigators. 
In this paper we report the results of our attempt to isolate and 
purify Sp53, the protective surface antigen of Plasmodium berghei 
sporozoites, and use it as an immunogen. For this purpose it was 
associated with phosphatidyl choline liposomes. Up to 80% of purified 
Sp53 could be incorporated into liposomes. Injection of these 
Sp53-liposomes into Balb/c mice induced antibodies that showed 
specificity for the surface component of P.berghei eporozoites and did 
not crossreact with asexual bloodstages of this species. 
Both a primary and a secondary response were induced the latter 
producing antibodies of the IgG class. A total of four injections were 
given at six weeks intervals. Three weeks after the fourth injection an 
4 
infective challenge inoculum was administered containing 10 viable 
sporozoites. None of the immunized mice showed any protection. All 
developed a patent parasitemia without any prolongation of the prepatent 
period compared with the control animals. The results are discussed in 
relation with other studies using a similar immunization model. 
INTRODUCTION 
The problem of malaria in the tropical world is becoming more and 
more critical, due to the development of multiple resistance to drugs by 
the malignant parasite Plasmodium falciparum (1). Active immunization of 
the population at risk would be a most we lic ome solution. The 
sporozoite, being the infective stage, is one of the targets for a 
specific inmune response. Immunization studies using intact viable or 
X-ray attenuated sporozoites of mammalian malarias resulted in a high 
degree of protection in rodents (2, 3), monkeys (4) and humans (5). 
Nothing, however, is known about the effectiveness of immunization using 
purified sporozoite protein. This is mainly due to the lack of 
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sufficient material and of a procedure for the purification of the 
antigen. In previous papers (6, 7) we have reported about the 
identification and purification of immunologically significant proteins 
on the surface of P.berghei sporozoites. One of the proteins, ЗрЗЗ, 
having an apparent molecular weight (AMW) of 53 kDaltons (kD) was 
identified as being identical to Pb44 described by Yoshida et al.(8, 9). 
In this study we have purified Sp53 on a larger scale. The purified 
protein has been incorporated into liposomal membranes. The 
"Sp53-liposomes" have been used to induce anti-sporozoite antibodies in 
mice. 
MATERIALS AND METHODS 
Isolation and purification of Sp53: 
P.berghei ANKA sporozoites were harvested and purified from 
infected Anopheles stephensi mosquitoes as described in (6). Purified 
sporozoites were finally pelleted in 1.5 ml Eppendorf cups and stored as 
such at -70oC until use. 
α 
Sp53 was isolated from combined pellets (containing up to 8x10 
sporozoites) by extraction in 3 ml lOmM Tris-O.SmM MgC1-0.5% TritonXlOO 
pH 8.0 (10 TTx) for 18 hr at 40C in the presence of ImM 
Phenyl-Methane-Sulfonyl-Fluoride (PMSF). After centrifugation for 15 min 
at 18,000 g the supernatant containing Sp53 was mixed with pure 
125 
I-labelled Sp53 (10,000 cpm) in 200 шМ Тгі -5піМ MgC 1-0.52 Triton 
X100 pH 8.0 (200 TTx) and chromatographed on a 60x2.6 cm column of 
Sephacryl S300 in the same buffer. The fractions containing the 
radioactive counts were pooled, adjusted to 0.5M NaCl and run three 
times through a 3 ml inmuno affinity column consisting of hybridoma 3D11 
antibodies (anti P.berghei sporozoites) covalenti/ coupled to Sepharose 
4B as described in (9). The bound fraction was eluted using 3 ml of 50mM 
citric acid-O.SZ Triton X100 pH 2.6 followed by 3ml of 200 TTx buffer 
containing 0.5M NaCl. The pH of the eluted fraction was immediately 
neutralized by adding solid Tris and dialyzed against 200 TTx-0.5M NaCl. 
Immuno affinity chromatography was repeated using a 1 ml column to 
concentrate the final solution. The resulting fraction was dialyzed 
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against lOmM Тгів-ІЗОшМ NaCl-0.5Z Triton X100 pH 8.0. 
Western blotting of purified Sp53: 
Non-labelled purified Sp53 was concentrated by TCA precipitation, 
washed with cold methanol and applied to SDS-PAGE in 0.7 mm thick slab 
gels. Subsequently the protein was blotted onto nitrocellulose filter 
paper (0.45 μπι Schleicher and Schuil) using the procedure of Towbin et 
al. (14). Sporozoite protein was visualized after incubating the 
blotstrips with diluted rabbit anti-eporozoite antibodies and 
125 
I-labelled Protein A by screen-enhanced exposure to Kodak XAR5 film. 
Incorporation into liposomes: 
This procedure has been described by Gerritsen et al.(10). 
2.5 mg phosphatidyl choline (PC) from egg yolk (Sigma, type V.E) 
was diluted in 2 ml chloroform (Analytical grade, Merck) and transferred 
to a round bottom glass tube. The chloroform was evaporated using N, 
influx. The dialyzed purified Sp53 solution (roughly 2 ml) was added to 
the dry lipid film. The lipid was dispersed by shaking for 5 min. The 
Sp53-lipid mixture was added to prewashed SM. beads (Bio-Rad), 0.3 g wet 
beads per ml dispersion. The tube was rotated end over end for 18 hr at 
4 С or for 2 hr at room temperature to remove the detergent as described 
by HolIowaу (11). After removing the supernatant the beads were washed 
twice with 2 ml of lOmM Tris-lSOmM NaCl pH 8.0. The Sp53-liposomes were 
concentrated from the pooled supernatants by centrifugation. 
Phospholipid was determined by the colorimetrie assay of 
Fiske-Subbarow (12) modified by Broeckhuyse (13). 
SDS-PAGE was carried out according to the procedure described in 
(7, 9). 
Silver staining of SDS-gels was performed using a Bio-Rad staining 
kit according to the manufacturers directions. 
Immunization schedule: 
Fifteen 10-week old female Balb/c mice were divided into three 
groups of five mice each. One group was intravenously injected with 
"Sp53-liposomes", one group with liposomes prepared without Sp53 and the 
third group was not treated. The liposomes were administered in 0.2 ml 
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Figure 1. Imnunoblotting of purified Sp53. Blotstrips of purified 
125 Sp53: strip A, incubated with control rabbit serum and I-labelled 
protein A. strip B: incubated with rabbit anti-sporozoite serum and 
125 
I-labelled protein A. The MW indications (in kD) refer to the 
positions of calibration proteins, which were run on SDS-PAGE and 
blotted in the same procedure as Sp53. 
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lOmM Тгіз-150шМ NaCl pH 8.0 per mouse in four sessions at six weeks 
8 intervals. The priming dose consisted of material purified from 7x10 
sporozoites, the second and third injections vere each derived from 
8 8 
3.5x10 sporozoites, whereas the final dose originated from 7x10 
sporozoites. 
Serum samples from both injected groups were taken at regular 
intervals. Immunofluorescence (IFA) was performed on air-dried as well 
as viable sporozoites and on air dried blood schizonts as antigens. All 
FITC-conjugates were purchased from Cappel labs. Circum sporozoite 
precipitation reactions (CSP) were carried out as described by 
Vanderberg (15). In CSP starting dilutions were 1:5, in IFA sera were 
first diluted 1:10. Hybridoma 3D11 (a gift from Prof. R. Nusaenzweig, 
New York), directed against the surface antigen of P.berghei 
sporozoites, was used as a positive control in all serological tests. 
RESULTS 
Purification and reconstitution of Sp53: 
125 
The recovery of the I-labelled Sp53 was about 70%. However, we 
have not been able to determine the amount of non-labelled purified 
Sp53. After purification of the third batch a sample was taken 
corresponding to 3x10 sporozoites (10% of the immunization dose), the 
protein was precipitated using Ivol 20% TCA, washed with cold methanol 
and applied to SDS-PAGE in a volume of 20 μΐ of sample buffer (16). The 
gel was stained with coomassie brilliant blue and silver (17). The 
former staining did not reveal any protein, whereas the latter technique 
demonstrated two very weak bands at 65kD and 53kD (on a 7.5% acrylamide 
gel). Using Western blotting of non-labelled material processed in 
exactly the same way it appeared, after immunological detection, that 
only the 53kD band was of sporozoite origin, being Sp53. The result of 
this analysis is shown in figure 1. Blotstrip 'a' was treated with 
control rabbit serum, strip 'b' with anti-sporozoite serum (rabbit). One 
can only roughly estimate the total amount of purified Sp53 in this 
batch. Since the detection limit for protein using the silver stain is 
in the order of 0.1-1 nanogram (17) the total yield from 3x10 
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Figure 2. Freeze fracturing of Sp53-lipo8omes. Inset A. Pellet of 
2hr 150,000 g, showing vesicles having diameters of 50 to 300 nm. Inset 
B. Supernatant after this centrifugation procedure, containing very 
small vesicles (diameter <100 nm). Magnification 100,000 X. 
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sporozoites must have been between 1 and 10 nanograms of Sp53. The 
percentage of purified Sp53 which could be incorporated into 
PC-liposomes or vesicles could be calculated only by measuring the 
125 incorporation rate of the I-labe lied Sp53 marker. Table I shows the 
distribution of Sp53 over the different size liposomes. About 10% of the 
protein was associated with the large liposomes (pellet of 5 min 18,000 
g), 70Ζ of Sp53 was bound to small liposomes (vesicles) (pellet of 2hr 
150,000 g), whereas 20Z could not be sedimented by the latter procedure. 
The protein-lipid ratio was the highest in the smaller liposomes. 
Freeze fracturing of the sediment (fig. 2A) and the supernatant 
(fig. 2B) of 2hr 150,000 g revealed that the small liposomes are mostly 
unilamellar and have diameters of 50-300 nm. In the supernatant very 
small vesicles were still present and were probably associated with the 
remaining 20% protein. For the immunization large and small liposomes 
were combined. 
Table I. Relative amount of Sp53 associated with liposomes of 
different size. 
large liposomes small liposomes supernatant 
pellet 5 min 18,000g pellet 2hr 150,000g 2hr 150,000f 
2-incorporation Sp53 10 70 20 
%-phospholipid 50 20 30 
Table 1. Relative amount of I-labelled Sp53 associated with 
liposomes of different size: the relative amount of Sp53 present in the 
different fractions was estimated by counting the radioactivity per 
fraction and relating that to the total number of counts present in all 
fractions. Phospholipid was determined using the Fiske-Subbarow assay. 
Results were obtained from four separate but reproducible experiments. 
85 
Φ о 
о 
cu 
6 
5 
4 
3 
2 
1 
0 
• 
* 
• 
• 
• 
• 
• 
• 
• 
I 
• 
• 
• 
-4- +. 
# 
• 
t 
• 
* 
» 
χ 
* 
л 
* 
: · 
* 
* * 
t : 
^ 
1 
* 
* 
i 
• 
• 
• 
• 
• 
1 
^ 
* 
: 
« 
* 
* 
t 
* 
• 
θ 10 12 14 16 18 weeks 
Figure 3. Anti-sporozoite antibodies in five different mice as a 
result of immunization with Sp53-lipo8omes. Five mice were injected with 
Sp53-lipo9omes at four occasions with six weeks intervals (arrows). 
Serum was taken regularly from all mice and analysed for anti-sporozoite 
antibodies using IFA (starting dilution was 1:10). Titers from all mice 
were plotted separately. The titer indices on the vertical axis refer to 
2 -1 
log(titer*10 ). For example a titer of 1:80 has titer index of 
2log8=3. 
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The effect of the imraunization: 
The amount of specific antibodies present in the serum samples of 
the immunized animals was determined using the IFA on air-dried 
sporozoite antigen. The results are shown in figure 3. This figure shows 
the IFA-titer of individal mice immunized with Sp53-lipoeomee, 
throughout the total experiment. The first dose apparently did contain 
sufficient liposome-bound antigen. It induced a primary antibody 
production, that was detectable from day 4, peaked on day 7 with titers 
up to 1:160 and disappeared after 'two to four weeks after the first 
injection. The second injection, although derived from half the amount 
of sporozoites used for the priming, gave rise to a secondary response 
in all immunized mice. The titer, however, dropped as early as two weeks 
after this booster. A third and a fourth injection did not have any 
significant boosting effect. 
Using class-specific conjugates it was shown that after the second 
injection all specific antibodies belonged to the IgC class. During the 
primary response no class differentiation was made. Throughout the 
immunization period all control mice remained negative in the IFA 
(titers <1:10). Sera from immunized mice were also tested in IFA on 
intact, viable sporozoites, as well as on air dried bloodstages as 
antigen. Titers determined using intact sporozoites were comparable with 
those from air-dried sporozoites. All tests using bloodstages were 
negative (titers <1:10). No positive (titers >1:5) CSP reactions were 
elicited. 
Three weeks after the final inoculation all three groups of mice 
4 
were given a challenge with 10 viable sporozoites intravenously. None 
of the immunized mice, however, showed any sign of protective immunity. 
All developed a patent parasitemia and the prepatent period was not 
significantly different from that of the control animals. 
DISCUSSION 
The amount of sporozoites needed to carry out an experiment like 
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this is without a doubt the main reason for the absence of reports on 
similar experiments in the literature. In order to illustrate this 
point, for the above described study we used the infected mosquito 
production of one whole year with the exception of a weekly quotum for 
other experiments. The only paper dealing with immunization using 
homogenized sporozoite fractions has been published by Spitalny and 
Nussenzweig in 1972 (18). Sporozoites were fragmented by either 
sonication or homogenization. This particulate material was fractionated 
and injected into mice. Although specific antibodies were induced in the 
pooled serum samples of these mice (undiluted serum gave a positive CSP 
reaction), none of the inmunized animals resisted an infective 
challenge. These experiments were done, however, with low numbers of 
non-purified sporozoites. 
In the present study we have purified the surface protein from 
sporozoites. We used liposomes as a membrane model for carrying and 
presenting the antigen, whilst they might act also as an adjuvant in 
enhancing the specific antibody response. 
The use of liposomes as a carrier for different molecules like 
enzymes or drugs has been extensively described (reviewed by Gregoriadis 
(19)). The stimulation of the immune response by liposomes has been 
investigated in two different models. Some investigators have worked 
with haptenated liposomes, low molecular weight molecules like 
di-nitrophenol (DNP) or arsenate covalently coupled to phospholipid in 
liposomal structures (20, 21). Others have studied the response to high 
molecular weight material such as proteins in the presence or in 
association with liposomes (22, 23). The apparent paradox in the 
immunology of liposomes is provided by the fact that in the 
carrier-hapten research one is looking for the most immunogenic carrier 
(liposome), whereas for the latter group of investigators the liposome 
should not be immunogenic of its own. The latter being favourable in a 
possible application of vaccines (24, 25). 
Clear evidence has been provided (a.o. by Van Rooyen and Van 
Nieuwmegen (26-28)) that the use of liposomes can, under certain 
conditions, enhance the humoral immune response against a proteinaceous 
antigen. Although liposomes, which were administered separately from the 
antigen could give some enhancement, the best result has been obtained 
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by liposomes associated with the antigenic protein. When the protein is 
accessible from the outside of the liposome, attached to or incorporated 
in the lipid bilayer, a better antibody response is induced than with 
protein trapped inside the liposome. Not only the primary response was 
enhanced but also the generation of immunological memory resulting in a 
better secondary response (24, 27). 
The phospholipid composition of the liposomes also determines the 
intensity of the stimulating effect but plays a minor role when compared 
to haptenated liposomes. The choise of the most abundant phospholipid in 
the liposome is therefore mainly determined by the affinity of the 
candidate protein for this phospholipid. From studies by Gerlier and 
Doré (reviewed in 29) it was shown that the polar head group as well as 
the acyl chain of the phospholipid are important in the association with 
the protein. The fluidity of the liposomal membrane, determined by 
cholesterol and the transition temperature of its individual lipid 
components, plays a major role in the immunoadjuvant effect of 
haptenated liposomes (21, 30). This seems to be hardly of importance, 
however, with regard to the immunogenicity of liposome-associated 
proteins (29). The surface charge of the liposomes, determined by the 
polar head group of the phospholipids is also not essential for a good 
adjuvant effect (Gregoriadis and Manee is (31) and Sanchez et al. (32)). 
Many investigators have used phosphatidyl choline as the major or only 
constituent of the liposomes due to its very low immunogenicity. 
Schuster et al. (33) have demonstrated that administration of 
PC-liposomes, even in the presence of Freunds incomplete adjuvant could 
not evoke any anti-PC antibody response. This is in marked contrast to 
cardiolipin, phosphatidyl inositol, phosphatidyl glycerol or 
phosphatidic acid (26). 
The orientation of the protein and especially membrane protein in 
the liposomal lipid bilayer is influenced by the method of preparation 
(reviewed by Eytan in 34). A gradual removal of detergent from 
lipid-detergent-protein mixtures (mixed micelles) favours an asymmetric 
insertion of the protein in the bilayer in an orientation similar to its 
native state. This is confirmed by results of Gerritsen et al. (10) 
investigating reconstitution of the human erythrocyte Band III protein 
in PC vesicles. 
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Different reports have been recently published concerning 
successful vaccinations using mostly viral proteins associated with 
liposomes. Gerlier et al.(35) and Sakai et al. (36) used Gross cell 
virus associated antigen and Balcarova et al. (37) the spike protein of 
the Semliki Forest virus. Siddiqui et al. (38) administered liposomes 
containing the immunostimulant muramyl-dipeptide separately from 
P.falciparum blood stage antigens and could enhance a specific antibody 
response. 
In our study we have tried to combine the available relevant data 
on this subject and apply them to the eporozoite vaccination model. The 
reconstitution of purified Sp53 with egg-PC liposomes was satisfactory. 
Up to 80% of the protein could be pelleted together with the liposomes, 
whereas the remaining 20% was probably also associated with lipid in 
very small vesicles. Similar incorporation values were also found by 
Gerritsen et al. (10), probably because of the hydrophobic character of 
both proteins (see also 7). More amphiphilic proteins like viral 
glycoproteins (35, 37, 39) were less easily reconstituted with 
phospholipids (30-50% incorporation). 
The amount of protein (Sp53) actually injected was in fact too low 
to be determined accurately. Based on detection limits of the silver 
staining (17) we could estimate that about 10 ng of Sp53 has been 
administered in the third injection. Compared with dosages of 0.1 pg to 
0.4 mg of protein used by others (24, 35, 37), 10 ng is perhaps too low 
to induce a solid and protective immunity. A possible cause for this 
unexpectedly low yield was the storage at -70 С of sporozoites for up to 
one year. Although in previous small scale experiments a coomassie blue 
positively staining amount of Sp53 was isolated from 2x10 sporozoites 
(40) there has possibly been a great difference between the various 
batches with respect to their preservation under these conditions. Orjih 
(41), however, reported also that storage at -70 С can be used to 
preserve the immunogenicity of sporozoites. 
Concluding we were able to induce a primary as well as a secondary 
antibody response in all immunized mice. The antibodies were 
specifically directed against a surface component of the sporozoite and 
did not cross react with P.berghei blood stage antigens. Investigators 
in molecular biology have developed tools to synthesize antigen in large 
90 
quantities, as for example the recently reported P.knowlesi sporozoite 
surface antigen (42). As such the possible application of liposomes as 
an adjuvant and as a presentation model for membrane bound antigens 
should be further investigated. Liposomes might well become an important 
constituent of future anti-malarial vaccines. 
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CHAPTER SIX 

GENERAL CONCLUSIONS AND PERSPECTIVES 
Malaria parasites continuously change their morphology, physiology 
and antigenic composition during the part of the lifecycle in the vector 
and the vertebrate host. The latter alteration interferes with the 
effect of an eventual immunologic attack by the host. Therefore it seems 
to be essential that an effective vaccine should focus on the antigens 
of one or more developmental stages of the parasite. The sporozoite 
being the stage that penetrates and infects the vertebrate host is 
therefore a logical candidate. 
Inmunization with intact sporozoites could under certain conditions 
lead to complete protection of the immunized individuals such as birds, 
rodents, monkeys and even human beings (reviewed by Cochrane et al. 
(1)). The aim of the present study has been to reveal the sporozoite 
antigens responsible for the induction of this immunity, and possibly 
use them in a purified form as a preliminary vaccine. A preceding study 
by Verhave (2) had already laid the foundation for this research 
project. The biology and immunology of the rodent malaria parasite 
Plasmodium berghei had been extensively studied and the techniques for 
the large scale production of P.berghei-in feeted mosquitoes was 
established during that study. 
Identification of sporozoite antigens: 
In order to identify proteins on the surface of sporozoites a more 
refined procedure had to be developed to purify sporozoites from the 
total mosquito homogenstes. The results of these investigations are 
described in chapter two of this thesis. The application of gradient 
centrifugation using Urografin and Percoli separated sporozoites from 
all mosquito debris as well as a substantial part of the microbial 
contaminants. These purified sporozoites were the starting material for 
the identification of the surface proteins. Using radio labe Hing by the 
125 lactoperoxidase catalyzed lodination procedure three proteins could 
be reproducibly detected. By means of SDS-PAGE their apparent molecular 
weight (AMW) was determined as being 110 kD (SpllO), 85 kD (Sp85) and 
53kD (Sp53). Using antibodies from rabbits and rats, specifically 
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directed against mature (ealivary gland) sporozoites it was shown that 
SpllO and Sp53 were actually present on the sporozoite surface. They did 
not react with antibodies from rats immunized against the bloods tage of 
the homologous parasite. These proteins were also detectable on the 
surface of immature sporozoites but probably in lower concentrations. 
Characterization of sporozoite surface proteins: 
The stage specificity of these proteins and their possible role in 
the induction of anti-sporozoite immunity stimulated a further study on 
the characterization of SpllO and Sp53. The results of these experiments 
are described in chapter three of this thesis. A procedure has been 
developed to extract the highest possible amount of both proteins from 
sporozoites. It appeared that SpllO and Sp53 do not only differ in size, 
but also in their hydrodynamic properties. SpllO was best solubilized by 
sonication in lOmM Trie buffer (pH 8.0), whereas Sp53 was totally 
aggregated by this procedure. The latter protein could be well extracted 
in the presence of detergent (Triton X100) in a buffer of low ionic 
strength. This procedure could solubilize more than 90% of Sp53 present 
in sporozoites. These results indicate that SpllO is a rather 
hydrophylic protein, whereas Sp53 has more hydrophobic properties. 
The presence of SpllO on the surface of the sporozoite became 
disputable, after it appeared that under different experimental 
conditions variable amounts of SpllO were labelled. The application of 
another labelling procedure (lodogen) did not label any significant 
amount of SpllO. These results suggested that the hydrogen peroxide 
necessary for the lactoperoxidase catalyzed reaction possibly damaged 
the outer membrane and so intracellular SpllO becomes labelled. Another 
explanation, however, might be that SpllO having double the size of Sp53 
is in fact generated by the labelling procedure itself and does not 
exist in the sporozoite as such. However, to our knowledge no examples 
are described in literature about the latter phenomenon. The only 
indication in this direction suggesting the above explanation might be 
correct originates from immuno-blotting studies such as described in 
chapter five. Using 3D11 as well as polyvalent rabbit serum we could not 
detect any SpllO in a non-labelled sporozoite extract, whereas Sp53 was 
very dominantly present (unpublished results). 
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Purification of sporozoite antigens: 
Despite the questions regarding SpllO a procedure was developed to 
purify both proteins after extraction. Using gel filtration on Sephacryl 
S300 in an appropriate buffer both proteins were eluted as almost pure 
fractions, as was determined by analysis on SDS-FAGE. Both proteins, 
however, showed an oligomeric configuration under these experimental 
conditions. SpllO and Sp53 were eluted from a calibrated column in 
fractions corresponding to an AMW of 300 kD and 250 kD respectively. 
Although fractions could be obtained containing almost pure labelled 
protein, the procedure could definitely be improved by the application 
of immuno-affinity-chromatography (IAC). Sepharose-coupled 3D11 
antibodies were used as immunoadsorbent. The results of these 
experiments are described in chapter four of this thesis. Gel filtration 
in combination with IAC provided a Sp53 solution which was not only 
purer, but also more concentrated which is another prerequisite for 
immunization purposes. 
The relationship of Sp53 to Fb44, and its precursors: 
In reports from another institute (Division of Parasitology, New 
York University Medical Center) a protein on the surface of P.berghei 
NK65 sporozoites was described having an AMW of 44kD (Pb44), as well as 
intracellular precursors of Pb44 designated as Pb54 and Pb52 (3). If 
Sp53 was similar to Pb44, a significant discrepancy existed between the 
AMW determinations in both laboratories. One of the apparent differences 
in the SDS-PAGE procedures was the acrylamide concentration of the 
separation gel. To investigate the effect of this difference purified 
Sp53 was separated on gels with different acrylamide concentrations. It 
was shown that the mobility of Sp53 varied with respect to the 
calibration proteins in different concentrations of acrylamide. These 
experiments are described in chapter four of this thesis. Theoretical 
considerations provided indications that the hydrophobic character of 
Sp53 was probably the cause of the different hydrodynamic properties 
related to the more hydrophilic calibration proteins. To confirm these 
observations Sp53 was run in the same gel together with Pb44, Pb52 and 
Pb54. It appeared that Sp53 was indeed identical to Pb44 and not to the 
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latter's intracellular precursors Pb52 and Pb54. This result strongly 
indicates that comparison of proteins of different strains and species 
can be very misleading, unless they are analyzed under identical 
experimental conditions. The actual molecular weight of especially a 
membrane protein can therefore only be determined by amino-acid 
sequencing of pure protein. 
Sp53 in liposomes, its application as an immunogen: 
The final goal of this project was the use of purified sporozoite 
antigen as immunogen. Sp53 was therefore purified from large batches of 
-70oC stored sporozoites. Since the amount of purified protein was 
expected to be very small, a model was developed to present the antigen 
to the immune system. It is known that the use of liposomes enhances the 
antibody response against certain antigens under appropriate 
experimental conditions. Another reason, however, to use liposomes as 
vehicles for Sp53 was the proper presentation of this hydrophobic 
protein. Incorporation into lipid bilayers might result in the exposure 
of the antigenic determinants more alike the native situation, than when 
it is randomly aggregated or solubilized in detergent (A). Chapter five 
describee the results of these experiments. 
Sp53 could be incorporated into phosphatidyl choline liposomes very 
efficiently. Nearly all Sp53 was associated with lipid after removal of 
the detergent. The protein/lipid ratio was the highest in small 
liposomes having a diameter of 50-300 nm. Most of these small liposomes 
were apparently unilamellar. The actual amount of protein incorporated, 
however, could not be assessed by the usual assays, because of the very 
low quantities present. Using SDS-PAGE in combination with 
immunoblotting or silver staining it was estimated that the yield of 
Sp53 from 3.5x10 sporozoites was in the order of 10 ng of protein. That 
such quantities of protein are insufficient to induce protective 
immunity is not surprising. Apart from protection, however, it was shown 
to be possible to use the Sp53-lipo8ome model to induce antibodies 
specific for the sporozoite stage and reactive with surface components 
of intact sporozoites. Both the primary and the secondary response were 
elicited the latter producing antibodies of the IgG class. Since this 
experiment was carried out using a one year production of infected 
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mosquitoes it has been impossible for us to repeat it with even more 
material. Very recently, however, new developments in the field of 
immunology and molecular biology have raised possibilities that this 
type of work can be continued. 
Recent advancements towards the development of a malaria vaccine: 
Recently a milestone was reached in malaria sporozoite research. 
Ellis et al. (5) in cooperation with the research group of Prof. R. 
Nussenzweig have succeeded in the production of the precursor of the 
surface antigen of P.knowlesi sporozoites in E.coli. After isolation of 
the mRNA from sporozoites a cDNA was synthesized. Fragments of this cDNA 
were transformed into E.coli bacteria. A clone could be selected which 
generated a polypeptide that reacted with the P.knowlesi MoAb. This 
polypeptide was identified as Pk50, the precursor of the P.knowlesi 
sporozoite surface protein. 
A "sporozoite vaccine" will probably the first to be developed 
among the candidate vaccines. After the report by Holder and Freeman (6) 
about the relatively successful immunization of mice using high 
molecular weight (MW) proteins from P.yoelii blood schizonts, high MW 
proteins were also described in asexual blood stages from other species 
like P.falciparum (7). A possible complication in this field of interest 
is the confirmation of the occurrence of antigenic variation in 
P.falciparum (8) first reported by Brown (9) in P.knowlesi. Recently an 
interference in the transmission of the malaria parasite to its vectors 
was shown to be effective (10, 11). Using extracellular gametes or 
zygotes as immunogen, antibodies could be induced that were able to 
block transmission of the parasite to the mosquito. Characterization of 
the antigens on P.falciparum gametes is now in progress. 
The influence of existing parasitemias and other infections on the 
immunocompetence of the vaccinated individual is one of the additional 
problems to be solved. The applicability of future antimalaria vaccines, 
however, will depend also on local socio-economic factors as well as on 
the attitude of future vaccine producing companies towards their 
customers in the Third World. 
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SAMENVATTING 
De ziekte malaria wordt veroorzaakt door een parasiet, behorende 
tot het geslacht Plasmodium en wordt overgedragen via de muskiet. Het 
malaria probleem is de laatste decennia weer sterk in omvang toegenomen 
mede gezien het mislukken van controle maatregelen zoals het uitroeien 
van de mug met behulp van insecticiden en het doden van de parasiet met 
antimalaria middelen. De mug heeft op grote schaal resistentie 
ontwikkeld tegen het meest gangbare, en goedkope, bestrijdingsmiddel 
DDT, en de parasiet heeft hetzelfde gedaan tegen bijna alle toepasbare 
geneesmiddelen inclusief het aloude kinine. Het welhaast laatst 
mogelijke redmiddel wordt momenteel gezocht in een actieve immunisatie 
primair tegen de verwekker van de voor de mens dodelijke malaria 
Plasmodium falciparum. De parasiet ondergaat echter gedurende zijn 
ontwikkeling in vector en gastheer een aantal ingrijpende veranderingen 
wat betreft voorkomen en samenstelling. Met name worden de eiwitten op 
de buitenmembraan van de parasiet bij elke gedaantewisseling vervangen. 
Dit maakt het voor de gastheer moeilijk om door middel van zijn 
afweersysteem de parasiet onschadelijk te maken. Het hier beschreven 
onderzoek heeft zich gericht op de bestudering van een bepaald stadium 
van de parasiet, in dit geval de sporozoiet. 
De sporozoiet is het stadium dat gevormd wordt in een kyste in de 
maagwand van de muskiet, nadat deze een geïnfecteerd bloedmaal heeft 
genomen. Wanneer de sporozoieten gevormd zijn barst de kyste open en 
migreren de sporozoieten massaal naar de speekselklieren van de muskiet. 
Deze injecteert bij een volgend bloedmaal een weinig speeksel waarin 
zich een aantal sporozoieten bevinden. De sporozoieten komen in de 
bloedbaan van de gastheer terecht en worden hieruit weggevangen door 
cellen van milt en lever. Van diegene die de lever bereikt hebben, 
ontwikkelt zich een gedeelte in de levercellen tot zgn. 
exo-erythrocytaire vormen, de voorlopers van het met ziekte 
verschijnselen gepaard gaande bloedstadium. 
In een experimenteel diermodel Plasmodium berghei in ratten en 
muizen is in een vijftal jaren voorafgaand aan dit onderzoek ervaring 
opgedaan met de biologie en de immunologie van het sporozoieten stadium 
en is de productie van grote aantallen geïnfecteerde muggen 
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gerealiseerd. Hierbij is komen vast te staan dat het mogelijk is een 
beschermende immuniteit te induceren door middel van injectie van 
intakte sporozoieten. Deze immuniteit is specifiek voor de soort en voor 
het ontwikkelingsstadium van de parasiet. 
In de hier beschreven studie is nagegaan welke eiwitten op het 
oppervlak van de sporozoiet aanwezig zijn en welke rol deze eiwitten 
vervullen bij de inductie van een beschermende immuniteit. In het eerste 
hoofdstuk wordt een overzicht gegeven van de ontwikkelingen die zich 
vanaf 1975 tot nu op dit gebied hebben voorgedaan. Daaruit blijkt vooral 
dat ondanks de vele jaren van intensief onderzoek de sporozoiet als 
functionele eenheid nog steeds geen open boek is. 
In het tweede hoofdstuk worden de resultaten beschreven van het 
onderzoek naar de eiwit samenstelling van het oppervlak van de 
sporozoiet. Alvorens tot de bestudering van deze eiwitten kon worden 
overgegaan, bleek het nodig de sporozoieten suspensies, verkregen uit 
totale muggen homogenaat, verder op te schonen. Dit is gelukt door 
toepassing van verfijnde centrifugatie methoden. Met behulp van eiwit 
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markerings technieken, met radioactief Jodium, kon een aantal 
eiwitten op het oppervlak van de sporozoiet zichtbaar gemaakt worden. Na 
analyse bleek dat twee eiwitten SpllO en Sp53 met een molekuul grootte 
van respectievelijk 110 kiloDaltons (kD) en 53 kD betrokken waren bij de 
immuniteit tegen de sporozoiet. 
In het derde hoofdstuk wordt beschreven hoe een isolatieprocedure 
voor beide eiwitten werd ontworpen, uitgaande van de fysisch-chemische 
eigenschappen van de betrokken eiwitten. Het resultaat hiervan was dat 
met name het Sp53 in bijna zuivere vorm uit sporzoieten geïsoleerd kon 
worden. Inmiddels was in New York ook onderzoek gedaan naar eiwitten op 
sporozoieten van dezelfde soort. Daar de resultaten van beide studies in 
detail van elkaar verschilden, is door ons de oorzaak hiervan 
onderzocht. De resultaten hiervan zijn beschreven in hoofdstuk vier van 
dit proefschrift. De verschillende uitkomsten bleken veroorzaakt te zijn 
door de wat extreme eigenschappen van het oppervlakte eiwit van de 
sporozoiet. Variaties in de experimentele condities gaven daardoor 
aanleiding tot een verschillende berekening van de vermoedelijke 
raolecuulgrootte van dit eiwit. Ter controle is een monster gezuiverd 
Sp53 in New York geanalyseerd onder dezelfde condities als en samen met 
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het door hen beschreven Pb44. Hierbij bleken beide eiwitten identiek te 
zijn. Hierbij is dus naar voren gekomen dat een vergelijking van 
membraan eiwitten op grond van hun vermoedelijke molecuulgrootte 
misleidend kan werken tenzij deze analyse is uitgevoerd onder identieke 
experimentele omstandigheden. De juiste molecuulgrootte kan alleen 
bepaald worden na een aminozuur sequentie-analyse van zuiver eiwit. 
In het vijfde hoofdstuk wordt een experiment beschreven dat het 
uiteindelijke doel van dit onderzoek geweest is: het immunizeren van 
proefdieren met een gezuiverd eiwit preparaat om specifieke antistoffen 
op te roepen, die zo mogelijk het dier zouden beschermen tegen 
infectieuze sporozoieten. Met behulp van een meer verfijnde zuiverings 
procedure is derhalve uit grote hoeveelheden sporozoieten het Sp53 
geïsoleerd. Om het aan te bieden aan het immuunsysteem is het eiwit 
ingebouwd in zgn. liposomen. Dit zijn kunstmatige membranen die een 
gesloten struktuur hebben en die onder bepaalde omstandigheden het 
immuun apparaat kunnen stimuleren. De dieren hebben in totaal vier 
injecties gekregen met dit liposoom-Sp53 complex. Het bleek mogelijk 
antistoffen op te roepen die specifiek reageerden met het oppervlak van 
de sporozoiet en niet met enig ander ontwikkelingsstadium van de 
parasiet. Na injectie met infectieuze sporozoieten bleek echter geen van 
de geimmunizeerde dieren beschermd te zijn. Dit betekent waarschijnlijk 
dat de hoeveelheid specifieke antistoffen in het serum van deze dieren 
ontoereikend is geweest om de levende sporozoieten te neutralizeren. Het 
is bij dit experiment namelijk gebleken dat de hoeveelheid ingespoten, 
gezuiverd eiwit dermate klein is geweest, dat het verwonderlijk genoemd 
mag worden dat er nog specifieke antistoffen werden opgeroepen. Hierbij 
zij nog vermeld dat voor bovenstaand experiment de productie van een 
jaar aan geïnfecteerde muggen nodig was. Het zal duidelijk zijn dat het 
onmogelijk is langs deze weg voldoende materiaal te verkrijgen nodig om 
bevolkingsgroepen in de tropische wereld te vaccineren. 
In het zesde en laatste hoofdstuk is ingegaan op de meest recente 
vorderingen op het gebied van een malaria vaccin en met name het 
sporozoieten vaccin. Via recombinant DNA technieken is men er onlangs in 
geslaagd het voorstadium van het oppervlakte eiwit van sporozoieten van 
een apemalaria te maken in E.coli bacteriën. Het zou derhalve van belang 
zijn te onderzoeken of dit eiwit, al dan niet ingebouwd in liposomen, in 
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Staat is een protectie te induceren in proefdieren. Naast de sporozoiet 
worden ook andere stadia van de malaria parasiet intensief bestudeerd. 
Ondanks het feit dat het onderzoek voor deze stadia nog niet zo ver 
gevorderd is, moet toch worden aangenomen dat een eventueel malaria 
vaccin zal bestaan uit een combinatie preparaat verkregen uit meerdere 
ontwikkelingsstadia. Of en zo ja wanneer een dergelijk vaccin toepepast 
zal worden voor de bestrijding van bevolkingsmalaria, wordt mede bepaald 
door factoren die buiten het werkterrein liggen van de wetenschappelijke 
onderzoeker. 
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STELLINGEN 
I 
Bij de bepaling van de molecuulgrootte van membraaneiwitten met behulp 
van SDS-PAGE wordt te weinig rekening gehouden met de invloed van de 
acrylamide concentratie van de scheidingsgel. 
II 
De toepassing van liposomen in vaccinatiestudies, met name als "carrier" 
van antigenen van infectieuze agentia verdient meer aandacht. 
III 
De discrepantie in molecuulgrootte, beschreven door Yoshida et al., voor 
Pb44 (44 kiloDaltons) en een eerder gepubliceerde waarde van 41 kD, is 
meer het gevolg van een verschil in meetcondities dan van proteolytische 
aktiviteit. 
N. Yoshida et al. Science (1980), 207, 71-73. 
IV 
De suggestie van Alving et al., dat galactoseresten bevattende liposomen 
kunnen interfereren met de binding van malariasporozoieten aan hepato-
cyten en zodoende een infectie verhinderen, is weliswaar theoretisch 
nragelijk maar verklaart geenszins hun experimentele bevindingen. 
CR. Alving et al., Science (1979), 205, 1142-1143 
V 
Het bestaan van de door Bray en Garnham "ontdekte" hypnozoieten van 
Plasmodium vivax ligt al opgesloten in de lange latentietijd, die 
Korteweg beschreef voor noord-hollandse malaria in 1902 en die hij 
bevestigde door experimentele infecties in 1929. Deze waarnemingen zijn 
waard om naar te refereren. 
R.S. Bray and P.C.C. Garnham, Brit. Med. Bull. (1982), 38, 117-122. 
P.C. Korteweg in: "Herinneringsbundel Prof. Rosenstein" Leiden 1902. 
VI 
Antigenen, die exclusief voorkomen op het gametenstadium, zijn 
waarschijnlijk van meer betekenis voor de ontwikkeling van een malaria 
"gameten vaccin" dan die, welke ook aanwezig zijn in gametocyten. 
J. Rener et al., J. Exp. Med. (1983), 158, 976-982. 
A.N. Vermeulen, persoonlijke bevindingen. 
VII 
In gebieden, waarvan verwacht mag worden, dat ze in de toekomst in 
aanmerking komen voor mogelijke experimentele toepassing van een malaria 
vaccin, dient jaren tevoren een begin gemaakt te worden met gedegen 
epidemiologisch malaria onderzoek. 
VIII 
De toepassingsmogelijkheden van de gen-therapie kunnen enorm worden 
verruimd, indien men de beschikking krijgt over specifieke, doelgerichte 
gen-carriers. Liposomen voorzien van specifieke cel- of orgaangerichte 
liganden kunnen als zodanig functioneren. 
C. Nicolau et al. Proc. Natl. Acad. Sci. USA (1983), 80, 1068-1072. 
P. Glosh et al. Arch. Biochem. Biophys. (1982), 213, 266-277. 
IX 
Voor het aantonen van specifieke IgM antistoffen met behulp van 
indirecte immuno-assays dient de storende invloed van specifieke IgG 
antilichamen, aanwezig in het te onderzoeken serummonster, te worden 
uitgesloten. 
X 
Er bestaan geen goede klinische criteria voor het aanvragen van 
parasitologisch faeces-onderzoek. Het moet daarom in meer gevallen 
worden aangevraagd, om te voorkomen dat men pathogène parasitosen 
miskent. 
L.K. Eveland et al. Am. J. Pubi. Health (1975), 65, 1326-1327. 
XI 
De orale opname van vitamine D,, zoals toegevoegd aan margarine, draagt 
niet bij tot het voorkomen van rachitis en osteomalacia. Het is 
bovendien onnatuurlijk en potentieel gevaarlijk. De enig juiste bron 
voor dit vitamine blijft ultra-violette straling. 
D.R. Fraser, The Lancet (1983), 8331, 969-972. 
XII 
Het terugbrengen van het lopende aantal abonnementen per tijdschrift tot 
één, leidt of tot verarming van de vakkennis van de wetenschappelijk 
medewerker of tot een drastische stijging van de kopieer- en portokosten 
van de Medische Faculteit. 
XIII 
Voor een bejaarde man als Sinterklaas is het onmogelijk de jaarlijks 
groeiende stroom "vakliteratuur" nog bij te houden. De middenstand zou 
hiermee, in haar reclamecampagnes, rekening kunnen houden. 
XIV 
Kankeronderzoek laat zich vergelijken met een tumor. 
Arno N. Vermeulen Nijmegen, 24 november 1983 




